CURRICULUM VITAE

                 DEBABRATA MUKHERJEE, MD, MS, FACC


Business Address:   Gill Foundation Professor of In...
01/89 - 12/92   Fellow in Molecular Cardiology, The Cleveland Clinic
                    Foundation, Cleveland, Ohio.


  ...
American College of Cardiology Career Development Award,
2002-2003


Cleveland Clinic Foundation, PPAR agonists for the pr...
NIH, GCRC Grant # M01 RR02602, Study # G5-0262, Effect of
                       Mineralocorticoid    Receptor     Antagon...
1990          American Heart Association Research Fellowship
     1990          Robert C Tarazi Fellowship Award for excel...
1993 - present American Medical Association
       1991 - present International Federation for the Advancement of Genetic
...
American Journal of Medicine
               Atherosclerosis
               Arteriosclerosis, Thrombosis and Vascular Biolo...
2007 -2010     Member, American College of Cardiology Task Force on
                             Clinical Expert Consensus...
7. Steinhubl SR, Lauer MS, Mukherjee D, Moliterno DJ, Ellis SG, and Topol EJ.
Pretreatment with ticlopidine reduces non-q ...
16. Mukherjee D, Nader S, Olano A, Garcia M, and Griffin BP. Improvement in right
ventricular systolic function after tric...
24. Mukherjee D, Roffi M, Kapadia S, Bhatt DL, Bajzer C, Ziada KM, Kalahasti V,
Hughes K, and Yadav JS Percutaneous Interv...
32. Mukherjee D, Bhatt DL, Robbins M, Roffi M, Cho L, Reginelli J, Bajzer
C, Navarro       F and Yadav JS. Renal artery   ...
40. Mukherjee D and Yadav J. Endovascular therapy for symptomatic vertebral artery
stenosis. Carotid Intervention 3 (3), 1...
48. Mukherjee D and Yadav J. Carotid artery intimal-medial thickness: indicator of
atherosclerotic burden and response to ...
56. Mukherjee D and Eagle KA. Cardiac risk in noncardiac surgery. Minerva
Cardioangiologica 50(6):607-19, December 2002


...
63. Mukherjee D and Eagle KA. Predictors of Missed Opportunities for Reperfusion in
ST-segment-elevation Myocardial Infarc...
72. Bates ER, Mukherjee D and Lau WC. Drug-Drug Interactions Involving Antiplatelet
Agents. Eur Heart J 24 (19); 1707-1709...
79. Mukherjee D, Hsu A, Moliterno DJ, Lincoff AM, Goormastic M and Topol EJ. Risk
Factors for Premature Coronary Artery Di...
86. Mukherjee D and Eagle KA. Treatment of the Post-Myocardial Infarction Patient
Journal of Clinical Outcomes Management ...
94. Saab FA, Eagle KA, Kline-Rogers E, Fang J, Otten R, and Mukherjee, D on behalf
of the Michigan Cardiovascular Outcomes...
101. Evangelista A, Mukherjee D, Mehta RH, O’Gara PT, Fattori R, Cooper JV, Smith
DE, Oh JK, Hutchison S, Sechtem U, Issel...
108. Nallamothu B, Saint M, Saint S and Mukherjee D. Double Jeopardy. New England
J Med 353:75-80, July 2005


109. Ziada ...
Give Similar Efficacy Outcomes at Trial (TARGET) 1-Year Follow-Up. Eur Heart J
26(23):2524-8, December 2005


115. Tsai TT...
The Global Registry of Acute Coronary Events (GRACE). Am Heart J 151:1130-1135,
May 2006


122. Shishehbor MH, Topol EJ, M...
129. Rajagopalan S, Dellegrottaglie S, Furniss AL, Gillespie BW; Satayathum S,
Lameire N, Saito A, Akiba T, Jadoul M, Gins...
136. Roffi M, Brandle M, Robbins MA, and Mukherjee D. Current Perspectives on
Coronary Revascularization in the Diabetic P...
142. Mukherjee D and Pineda G. Extracranial Vertebral Artery Intervention. J Interv
Cardiol 20(6):409-16, December 2007


...
153. Shah A, Banerjee T and Mukherjee D. Coronary, peripheral and cerebrovascular
disease: a complex relationship. Herz (i...
4. Mukherjee D, McTiernan CF and Sen S. Effect of myotrophin on induction of proto -
oncogenes, ANF and contractile elemen...
(Presented at the 48th Scientific session of the American College of Cardiology as a
Young Investigator Award Finalist).

...
Platelet glycoprotein IIb/IIIa inhibition – Results from PARAGON B. Circulation
102(18), II - 591, 2000 (Presented at the ...
22. Roffi M, Bhatt DL, Mukherjee D, Chew DP, Ziada KM, Prosper DM, Ellis SG,
Topol EJ. Stents and glycoprotein IIb/IIIa bl...
28. Mukherjee D, Bhatt DL, Roffi M, Ziada KM, Hughes K, Bajzer C, Krieger D,
Whitlow P and Yadav JS. Treatment of Symptoma...
Circulation 104(17), II - 711, 2001 (Presented at the 74th Scientific session of the
American Heart Association).


34. Mu...
40. Mukherjee D, Gurm H, Tang WH, Roffi M Wolski K, Moliterno DJ, Guetta V,
Ardissinio D, Bode C, Steg G, Lincoff AM, and ...
Eur Heart J 23: Suppl, pp 610, 2002 (Presented at the European society of Cardiology
Congress, September 2002, Berlin, Ger...
51. Mukherjee D, Dey S, Lingam P, Chetcuti S, Grossman PM, Moscucci M,
Rajagopalan S, Luciano AE, Eagle KA. Predictors of ...
56. Zhou X, Mukherjee D, Zhou Z, Lincoff AM, Wang K . A combination of a
selective factor Xa inhibitor and full dose tPA i...
61. Mukherjee D, Giri K, Fang J, Chetcuti S, Moscucci M, Kline-Rogers E, and Eagle
KA. Impact of Combination Evidence-Base...
A, 198A, 2005 (Presented at the 54th Scientific session of the American College of
Cardiology).


67. Mukherjee D, Eagle K...
on Outcomes of Patients Admitted with Acute Coronary Syndrome Circulation 112(17),
Suppl II, II-526, 2004 (Presented at th...
October 2006 (Presented at the Transcatheter Cardiovascular Therapeutics Symposium,
October 2006, Washington, DC).


77. D...
Mukherjee D, Cho L, Moliterno DJ (eds). 900 Questions: An interventional cardiology
board review. Philadelphia, PA: Lippin...
4. Mukherjee D, Wilkoff BL, Yadav JS. Angioplasty and Stenting of a Patient with
Superior Vena Cava Syndrome.         In: ...
12. Mukherjee D and Bates ER. Acute ST elevation myocardial infarction. In Eagle KA,
Practical Cardiology. Philadelphia, P...
19. Mukherjee D. Diagnostic Catheter-based Vascular Angiography. In Rajagopalan S,
Mukherjee D and Mohler E (eds). Manual ...
27. Mukherjee D and Eagle KA. Pre and Post-operative Management of Cardiovascular
Diseases and Risks in Patients with Peri...
34. Eagle K and Mukherjee D. Pharmacotherapy for Global Cardiovascular Risk
Reduction. In Mukherjee D (ed) Pharmacological...
42. Falluji N and Mukherjee D. Cerebrovascular interventions. In Mukherjee D, Cho L,
Moliterno DJ (eds). 900 Questions: An...
50. Das P and Mukherjee D. Bioabsorbable stents. In Topol EJ, Textbook of
Interventional Cardiology, 5th Edition. Philadel...
57. Moliterno DJ and Mukherjee D. Chronic Total Occlusion In CATHSAP 3
[Catheterization and Interventional Cardiology Self...
65. Mukherjee D and Roffi M. Coronary Artery Disease In Cho L and Griffin B (eds)
The Cardiology Intensive Board Review Qu...
74. Roffi M and Mukherjee D. Peripheral Arterial Angiography, Carotid Angiography
and Interventions In ACCSAP 7 [American ...
Therapy, Miami, Jan 23, 2001)


Newer modalities of therapy in the treatment of Coronary Artery Disease (University of
Mic...
Management of Peripheral Vascular Diseases (Henry Ford Hospital and Vascular
Institute, Detroit, Michigan, Cardiology Gran...
Michigan, November 1st, 2003)


Further Management of a Patient Discharged with the Diagnosis “Acute Coronary
Syndrome” (U...
Percutaneous Revascularization: Well Beyond the Coronary Arteries (Kentucky Chapter
of the American college of cardiology ...
Cardiology Urgencies and Emergencies for the Hospitalist (Hospitalist CME Series,
Philadelphia, September 26th, 2005)


Ca...
Curriculum Vitae (.DOC).doc.doc.doc
Curriculum Vitae (.DOC).doc.doc.doc
Curriculum Vitae (.DOC).doc.doc.doc
Curriculum Vitae (.DOC).doc.doc.doc
Curriculum Vitae (.DOC).doc.doc.doc
Upcoming SlideShare
Loading in...5
×

Curriculum Vitae (.DOC).doc.doc.doc

3,196

Published on

0 Comments
1 Like
Statistics
Notes
  • Be the first to comment

No Downloads
Views
Total Views
3,196
On Slideshare
0
From Embeds
0
Number of Embeds
0
Actions
Shares
0
Downloads
13
Comments
0
Likes
1
Embeds 0
No embeds

No notes for slide

Curriculum Vitae (.DOC).doc.doc.doc

  1. 1. CURRICULUM VITAE DEBABRATA MUKHERJEE, MD, MS, FACC Business Address: Gill Foundation Professor of Interventional Cardiology Associate Professor of Internal Medicine Director of Cardiac Catheterization Laboratories Director of Peripheral Intervention Program Gill Heart Institute, Division of Cardiovascular Medicine University of Kentucky 900 S. Limestone Street, 326B Wethington Building Lexington, KY 40536-0200 Tel: 859-323-5630 Fax: 859-323-6475 Email: Mukherjee@uky.edu Home Address: 4390 Clearwater way Lexington, KY 40515 Tel: 859 271 8472 Email: dmukherjee@pol.net Education: 1988 MD, Government Medical College, Nagpur (India) 1990 ECFMG Certified 1990 FLEX 1990 Medical Council of Canada, Evaluating Examination 2001-03 Masters in Clinical Research (University of Michigan) Professional Experience:
  2. 2. 01/89 - 12/92 Fellow in Molecular Cardiology, The Cleveland Clinic Foundation, Cleveland, Ohio. 01/93 - 02/96 Resident in Internal Medicine, The Cleveland Clinic Foundation, Cleveland, Ohio. 06/96 – 06/99 Fellow in Clinical Cardiology, The Cleveland Clinic Foundation, Cleveland, Ohio. 07/99 – 06/00 Fellow in Interventional Cardiology and Peripheral Vascular Interventions, The Cleveland Clinic Foundation 07/00 – 06/01 Chief Interventional Cardiology Fellow, The Cleveland Clinic Foundation 07/01 –09/04 Director of Peripheral Vascular Interventions for Cardiology, Assistant Professor Division of Cardiology, University of Michigan 10/04 – present Gill Foundation Professor of Interventional Cardiology, Director of Peripheral Vascular Interventions 07/06-present Director Cardiac Catheterization Laboratories, University of Kentucky Grant Support: American Heart Association Grant-in-Aid, 1999-2001 (Northeast Ohio chapter) 2
  3. 3. American College of Cardiology Career Development Award, 2002-2003 Cleveland Clinic Foundation, PPAR agonists for the prevention of adverse events following percutaneous coronary revascularization, 2002-2003, [Role – Local PI] Astra Zeneca, A 104-Week, Open-Label, Multi-Center, Phase IIIb Study Evaluating The Effect Of Treatment With Rosuvastatin 40 mg On Atherosclerotic Disease As Measured By Intravascular Ultrasound And Quantitative Coronary Angiography In Subjects Undergoing Coronary Angiography Who Have Coronary Artery Disease, 2003-2004, [Role – Local PI] PFIZER, A Phase 3, Multi-Center, Double-Blind, Randomized, Parallel Group, Coronary Artery Intravascular Ultrasound Evaluation of the Anti-Atherosclerotic Efficacy, Safety and Tolerability of Fixed Combination CP-529,414/Atorvastatin Administered Orally, Once Daily (QD) for 24 Months, Compared with Atorvastatin alone, in subjects with Angiographically Documented Coronary Heart Disease, 2004-2006, [Role – Local PI] Sanofi-Aventis, A randomized dose ranging Study of Hexasaccharide including active control, in patients with Unstable Angina or Non ST-segment Elevation Myocardial Infarction scheduled to undergo Percutaneous Coronary Intervention (SHINE), 2005 -2007, [Role – Local PI] Conor Medsystems, COSTAR II trial (CObalt chromium STent with Antiproliferative for Restenosis), 2005-2007, [Role – Local PI] 3
  4. 4. NIH, GCRC Grant # M01 RR02602, Study # G5-0262, Effect of Mineralocorticoid Receptor Antagonism on Thrombosis, Inflammation, and Oxidative Stress in Patients with Acute Coronary Syndromes, 2005-2006, [Role – Co Principal Investigator and Mentor] Abbott Vascular CAPTURE – 2, Post-market surveillance to document clinical outcomes involving the RX ACCULINK Carotid Stent System and RX ACCUNET Embolic Protection System (EPS) [Role – Local PI] Licensure: Ohio Medical license Michigan Medical license Kentucky Medical license Board Certification: 1996 Internal Medicine 1999 Cardiovascular Diseases 2000 Interventional Cardiology 2005 Recertification in Internal Medicine 2005 Recertification in Cardiovascular Disease Awards and Honors: 1979-86 Recipient of State Scholarship 1986 Recognition Award, Indian Council of Medical Research 1988 LN Jaiswal Gold Medal - First in University (MD) 1988 Sadiq Vali Gold Medal - First in Pediatrics (MD) 1988 DB Jaiswal Gold Medal - First in Medicine (MD) 4
  5. 5. 1990 American Heart Association Research Fellowship 1990 Robert C Tarazi Fellowship Award for excellence in cardiovascular research 1991 American Heart Association Research Fellowship 1997 Bristol – Myers Squibb Travel Award, American Heart Association 70th Scientific Sessions 1998 Affiliate Travel Award, American college of Cardiology 47th Scientific Sessions 1999 Young Investigator Award Finalist, American College of cardiology 48th Scientific Sessions 1999 Astra-Zeneca Young Investigator Award Finalist 1999 First prize for Abstract, 9th Annual sessions of the Ohio chapter of the American College of Cardiology 2000 Astra-Zeneca Young Investigator Award Finalist 2000 First prize for Abstract, 10th Annual sessions of the Ohio chapter of the American College of Cardiology 2001 Joseph Cash Memorial Award for excellence in Health outcome research 2002-03 American College of Cardiology/William F. Keating Career Development Award for Hypertension and Peripheral Vascular Disease 2003-2004 University of Michigan Cardiovascular Center McKay Research Grant for Peripheral Arterial Disease 2006 Who’s Who in America 2007-08 Best Doctors in America Memberships: 2005 – presentFellow of the Society for Vascular Medicine and Biology 2003 - present Fellow of the American College of Cardiology 1996 - present American College of Cardiology 1993 - present American College of Physicians 5
  6. 6. 1993 - present American Medical Association 1991 - present International Federation for the Advancement of Genetic Engineering and Biotechnology 1990 - present American Heart Association 1989 - present American Association for the Advancement of Science 1984 -1985 Indian Council of Medical Research Teaching Activities: 2001 – 2002 Mentor, Undergraduate Research Opportunity Program (UROP) 2001 – 2004 Fellow supervisor, Cardiac Catheterization Laboratory at UMHS 2001 – 2004 Staff Attending, Cardiology Consult Service at UMHS 2001 – 2003 Medical Student Research Mentor 2004 – presentFellow supervisor, Cardiac Catheterization Laboratory at UK 2001 – presentStaff Attending, Cardiology Consult Service at UK 2005-present K30 Research Mentor for Dr Rohit Bhatheja Professional Activities: 1997 - 1998 Clinical Events Committee, EPISTENT study 1998 – 1999 Clinical Events Committee, SYMPHONY study 2000 – 2001 Clinical Events Committee, TARGET study 2004 – 2005 Data Safety Monitoring Committee, STEEPLE Study 2004- 2005 Steering Committee, TENACITY study 2006– 2008 Steering Committee, MR PCI Study 2006– present Data Safety Monitoring Committee, PRECISION Study 2006– present Steering Committee, MIDAS Study 2001–present Manuscript reviewer: American Heart Journal American Journal of Cardiology American Journal of Hypertension 6
  7. 7. American Journal of Medicine Atherosclerosis Arteriosclerosis, Thrombosis and Vascular Biology Circulation Cleveland Clinic Journal of Medicine European Heart Journal Heart Journal of the American College of Cardiology JAMA Joint Commission Journal on Quality and Patient Safety Lancet Nature Clinical Practice Cardiovascular Medicine Stroke The Journal of Rheumatology Vascular Medicine CMAJ 2003 National Heart Lung and Blood Institute Special Emphasis Panel (Ancillary Pharmacogenetic Studies) 2003 Canadian Institute of Health Research (External reviewer) 2002–2006 Assistant Editor, ACC Current Journal Review 2006-present Associate Editor, ACC Cardiosource Review Journal 2003- present Editorial Board, Vascular Disease Prevention 2004-present International Editor, The Reviews 2005- present Editorial Board, International Journal of Angiology 2005- present Editorial Board, American Heart Journal 2006- present Editorial Board, Indian Heart Journal 2006- present Editorial Board, Recent Patents on Cardiovascular Drug Discovery 2006- present Editorial Board, American Journal of Managed Care 2007-present Editorial Board, The Open Health Services and Policy Journal 2005 -2008 Member, Cardiac Catheterization and Intervention Committee, American College of Cardiology 2006-2009 American College of Cardiology i2 Summit Advisory Work Group 7
  8. 8. 2007 -2010 Member, American College of Cardiology Task Force on Clinical Expert Consensus Documents 2007 -2010 Heart Education Advisory and Research Team, (HEART), Commonwealth of Kentucky 2008 – 2013 Editor–in-Chief, Cardiology Reviews 2008 - 2011 Member, Cardiac Catheterization and Intervention Committee, American College of Cardiology Publications: 1. Mukherjee D and Sen S. Collagen phenotypes during development and regression of myocardial hypertrophy in spontaneously hypertensive rats. Circ Res 67: 1474-80, 1990. 2. Mukherjee D and Sen S. Alteration of collagen phenotypes in ischemic cardiomyopathy. J Clin Inv 88: 1141- 46, 1991. 3. Mukherjee D, McTiernan CF and Sen S. Myotrophin induces early response genes and causes enhanced cardiac gene expression. Hypertension 21: 142 - 48, 1993. 4. Mukherjee D and Sen S. Alteration of collagen phenotypes in hypertensive hypertrophy: Role of blood pressure. J Mol Cell Cardiol 25: 185 - 96, 1993. 5. Mukherjee D, Lange P, Sferry C, Joseph J and Mehta A. Dyspnea, cough and chest pain in a 35-year-old woman. Chest 107: 1460 - 62, 1995. 6. Sil P, Mukherjee D and Sen S. Quantification of myotrophin from spontaneously hypertensive and normal rat hearts. Circ Res 76(6): 1020 - 27, 1995. 8
  9. 9. 7. Steinhubl SR, Lauer MS, Mukherjee D, Moliterno DJ, Ellis SG, and Topol EJ. Pretreatment with ticlopidine reduces non-q wave myocardial infarctions following intracoronary stenting. J Am Coll Cardiol 32(5): 1366-70, 1998. 8. Mukherjee D, Bhatt DL, Roe MT, Patel V and Ellis SG. Direct Myocardial Revascularization and Angiogenesis - How Many Patients Might be Eligible? Am J Cardiol 84(5): 598-600, 1999. 9. Ellis SG, Cura FA and Mukherjee D. Prospects for therapeutic angiogenesis and myogenesis in patients with advanced coronary disease. J Invasive Cardiol 11(10): 615-17, 1999. 10. Mukherjee D and Moliterno DJ. Prompt Use of Reteplase (RetavaseTM) For Acute Myocardial Infarction: Facilitating Percutaneous Coronary Intervention and Early Hospital Discharge. J Invasive Cardiol [Clinical Case Update] Vol 2(2); March 2000 11. Bishay ES, McCarthy PM, Cosgrove DM, Hoercher KJ, Smedira NG, Mukherjee D, White J, and Blackstone EH. Mitral valve surgery in patients with severe left ventricular dysfunction. Euro J CardioThoracic Surg; 17:3:213-221, March 2000 12. Mukherjee D and Moliterno DJ. Applications of anti-platelet monitoring in the catheterization laboratory. J Thrombosis and Thrombolysis 9(3): 293-301, April 2000 13. Mukherjee D and Moliterno DJ. Achieving tissue-level perfusion in the setting of Acute Myocardial Infarction. Am J Cardiol 85 (8A): 39C – 46C, April 2000 14. Mukherjee D, Wong J, Griffin BP, Ellis SG, Porter T, Sen S, and Thomas JD. Ten fold augmentation of endothelial uptake of vascular endothelial growth factor with ultrasound after systemic administration.. J Am Coll Cardiol 35(6): 1678-86, May 2000. 15. Mukherjee D and Ellis SG. Use of rescue angioplasty for failed thrombolysis. Cleveland Clinic J of Medicine 67(5): 341–352, May 2000 9
  10. 10. 16. Mukherjee D, Nader S, Olano A, Garcia M, and Griffin BP. Improvement in right ventricular systolic function after tricuspid valve surgery for isolated severe tricuspid regurgitation. J Am Soc Echo 13(7):650-654, July 2000 17. Mukherjee D and Ellis SG. New options for untreatable coronary artery disease: Angiogenesis and Laser revascularization. Cleveland Clinic J of Medicine 67(8): 577 – 583, August 2000. 18. Mukherjee D, Reginelli JP, Moliterno DJ, Yadav SJ, Schneider JP, Raymond R, Whitlow PL, Franco I, and Ellis SG. Unexpected Mortality reduction with abciximab for in-stent restenosis. J Invasive Cardiology 12(11): 540-544, Nov 2000 19. Mukherjee D and Yadav SJ. Carotid and cerebrovascular disease. Cardiology in Review 8 (6): 322–332, Nov 2000 20. Mukherjee D and Moliterno DJ. Monitoring antiplatelet therapy: What is the best method? Clinical Pharmacokinetics, 39(6): 445-458, Dec 2000 21. Moliterno DJ and Mukherjee D. Applications of monitoring platelet glycoprotein IIb/IIIa antagonism and low-molecular-weight heparins in cardiovascular medicine. Am Heart J, 140 (6 Pt 2):S136-S142, Dec 2000 22. Mukherjee D and Yadav SJ. Carotid angioplasty and stenting in high-risk patients. Carotid Intervention 3 (1), 13-15, Jan 2001 23. Mukherjee D, Chew DP, Robbins M, Yadav J, Raymond RE, and Moliterno DJ. Clinical Application of Procedural Platelet Monitoring During Percutaneous Coronary Intervention Among Patients at Increased bleeding Risk. J Thrombosis and Thrombolysis 11, 143 – 146, April 2001 10
  11. 11. 24. Mukherjee D, Roffi M, Kapadia S, Bhatt DL, Bajzer C, Ziada KM, Kalahasti V, Hughes K, and Yadav JS Percutaneous Intervention for symptomatic vertebral artery stenosis using coronary stents. J Inv Cardiology 13, 363-366, May 2001 25. Mukherjee D and Yadav SJ. Effect of Contralateral Occlusion on long-term Efficacy of Endarterectomy in the Asymptomatic Carotid Atherosclerosis Study (ACAS). Stroke 32(6):1443-1448 June 2001 26. Mukherjee D, Comella K, Bhatt DL, Roe MT, Patel V and Ellis SG. Clinical Outcome of a Cohort of Patients Eligible for Therapeutic Angiogenesis or Transmyocardial Revascularization Am Heart J 142: 72-74, July 2001 27. Mukherjee D and Yadav SJ. Update on peripheral vascular diseases: From smoking cessation to stenting. Cleveland Clinic J of Medicine 68: 723-734, August 2001 28. Mukherjee D, Nissen SE, Topol EJ. Risk of Cardiovascular Events Associated With selective COX-2 Inhibitors. JAMA 286: 954-959, August 2001 29. Chew DP, Bhatt DL, Robbins M, Mukherjee D, Roffi M, Schneider JP, Topol EJ, and Ellis SG. Effect of clopidogrel added to aspirin before percutaneous coronary intervention on the risk associated with C-reactive protein. Am J Cardiol 88(6): 672-674, September 2001 30. Mukherjee D and Eagle KA. Increase in Peripheral Interventional Procedures by Cardiologists – Are Patients being Served? Effective Clin Practice 4: 221-222, October 2001 31. Mukherjee D, Nissen SE, Topol EJ. COX-2 inhibitors and cardiovascular risk. We defend our data and suggest caution. Cleveland Clinic J of Medicine 68: 963-964, November 2001 11
  12. 12. 32. Mukherjee D, Bhatt DL, Robbins M, Roffi M, Cho L, Reginelli J, Bajzer C, Navarro F and Yadav JS. Renal artery end diastolic velocity and renal artery resistance index as predictors of outcome after renal stenting. Am J Cardiol 88(9): 1064-66, Nov 2001 33. Mukherjee D, Kalahasti V, Bhatt DL, Roffi M, Ziada KM, Hughes K, Bajzer C, and Yadav JS. Self-expanding stents for carotid intervention: Comparison of Nitinol versus stainless steel stents. J Inv Cardiol 13(11):732-735, Nov 2001 34. Mukherjee D. Therapeutic angiogenesis in the treatment of coronary artery disease. Cardiology Update 1(1): 100-106, Dec 2001 35. Bhatt DL, Kapadia SR, Bajzer CT, Chew DP, Ziada KM, Mukherjee D, Roffi M, Topol EJ and Yadav JS. Dual Antiplatelet Therapy with Clopidogrel and Aspirin after Carotid Artery Stenting. J Inv Cardiol 13: 767-771, 2001 36. Mukherjee D, Nissen SE, Topol EJ. Cardiovascular Events and COX-2 Inhibitors. JAMA. 286:2808-2813, Dec 2001 37. Roffi M, Chew DP, Mukherjee D, Bhatt DL, White JA, Heeschen C, Hamm CW, Moliterno DJ, Cakliff RM, White HD, Kleiman NS, Theroux P, Topol EJ. Platelet Glycoprotein IIb/IIIa Inhibitors Reduce Mortality in Diabetic Patients with Non-ST- Segment Elevation Acute Coronary Syndromes. Circulation 104:2767-71, Dec 2001 38. Mukherjee D, Roffi M, Bajzer C, and Yadav J. Endovascular Treatment of Carotid Artery Aneurysms with Covered Stents. Circulation 104(24):2995, Dec 2001 39. Roffi M, Robbins MA, Mukherjee D, Bhatt DL, Bajzer C, Yadav JS. Carotid stenting with emboli protection device. Images in Cardiovascular Medicine. Kardiovaskulare Medizin 4:347-8, Dec 2001 12
  13. 13. 40. Mukherjee D and Yadav J. Endovascular therapy for symptomatic vertebral artery stenosis. Carotid Intervention 3 (3), 13-15, Jan 2002 41. Mukherjee D. Selective Cox-2 Inhibitors and Potential Risk of Cardiovascular Events. Biochem Pharmacol 63 (5), 817-821, March 2002 42. Mukherjee D, Roffi M, and Yadav J. Endovascular Treatment of Carotid Artery Aneurysms with stent grafts. J Invasive Cardiol 14: 269-72, May 2002 43. Mukherjee D and Topol EJ. Pharmacogenomics in cardiovascular diseases. Prog Cardiovasc Dis 44 (6), 479 – 498, June 2002 44. Roffi M, Chew DP, Mukherjee D, Bhatt DL, White JA, Moliterno DJ, Heeschen C, Hamm CV, Robbins MA, Kleinman NS, Théroux P, White HD, Topol EJ. Platelet Glycoprotein IIb/IIa Inhibition in Acute Coronary Syndromes: Gradient of Benefit Related to the Revascularization Strategy. European Heart Journal 23: 1441–1448, September 2002 45. Mukherjee D and Eagle KA. Coronary revascularization prior to elective vascular surgery: Does it reduce cardiac risk? J Vascular Surgery 36:644-645, September 2002 46. Mukherjee D, Lingam P, Chetcuti S, Grossman PM, Moscucci M, Luciano AE, and Eagle KA. Missed Opportunities to Treat Atherosclerosis in Patients Undergoing Peripheral Vascular Interventions: Insights From the University of Michigan Peripheral Vascular Disease Quality Improvement Initiative (PVD-QI2) Circulation 106:1909-1912; October 2002 47. Mukherjee D and Topol EJ. The Role of Low-Molecular Weight Heparin in Cardiovascular Diseases. Prog Cardiovasc Dis 45(2): 139 –156, October 2002 13
  14. 14. 48. Mukherjee D and Yadav J. Carotid artery intimal-medial thickness: indicator of atherosclerotic burden and response to risk factor modification. Am Heart J 144; 753-759, November 2002 49. Mukherjee D and Eagle KA. A common sense approach to peri-operative evaluation. Am Fam Physician 66:1824-26, November 2002. 50. Mukherjee D and Yadav J. Percutaneous Treatment for Carotid Stenosis. Cardiology Clinics 20(4): 589-97, November 2002 51. Chan AW, Bhatt DL, Wilkoff BL, Roffi M, Mukherjee D, Gray BH, Baizer CT, and Yadav JS. Percutaneous treatment for pacemaker-associated superior vena cava syndrome. Pacing Clin Electrophysiol 25(11):1628-33, November 2002 52. Mukherjee D, Gurm H, Tang WH, Roffi M Wolski K, Moliterno DJ, Guetta V, Ardissinio D, Bode C, Steg G, Lincoff AM, and Topol EJ. Outcome of Acute ST- segment Elevation Myocardial Infarction in Patients With Prior Coronary Artery Bypass Surgery Treated with Combination Reduced Fibrinolytic Therapy and Platelet Glycoprotein IIb/IIIa Inhibition. Am J Cardiol 90:1198–1203, December 2002 53. Mukherjee D, Nissen SE, and Topol EJ. Lack of cardioprotective effect of naproxen. Archives of Internal Medicine 162(22): 2637 December 2002 54. Roffi M, Mukherjee D, Chew DP, Bhatt DL, Cho L, Robbins MA, Ziada KM, Brennan DM, Ellis SG, Topol EJ. Lack of Benefit from Intravenous Platelet Glycoprotein IIb/IIIa Receptor Inhibition as Adjunctive Treatment for Percutaneous Interventions of Aortocoronary Bypass Grafts: A Pooled Analysis of Five Randomized Clinical Trials. Circulation 106: 3063 –3067, December 2002 55. Tamirisa K and Mukherjee D. Gene therapy in cardiovascular diseases. Curr Gene Therapy 2 ( 4): 427-435, December 2002 14
  15. 15. 56. Mukherjee D and Eagle KA. Cardiac risk in noncardiac surgery. Minerva Cardioangiologica 50(6):607-19, December 2002 57. Mukherjee D, Mahaffey KW, Moliterno DJ, Harrington RA, Yadav J, Pieper KS, Gallup D, Dyke C, Roe MT, Berdan L, Lauer M, Mänttäri M, White HD, Califf RC, and Topol EJ. The promise of combined Low-Molecular-Weight Heparin and platelet Glycoprotein IIb/IIIa Inhibition--Results from PARAGON B. Am Heart J 144: 995 – 1002, December 2002 58. Mukherjee D, and Topol EJ. COX-2: Where are we in 2003? Arthritis Research 5(1): 8 – 11, January 2003 59. Chan AW, Roffi M, Mukherjee D, Bajzer C, Abou-Chebl A, Ciezki J, Bhatt DL, Ghaffari S, and Yadav J. Carotid brachytherapy for in-stent restenosis. Cathet Cardiovasc Intervent 58(1): 86-92, January 2003 60. Cura FA, Kapadia SR, L'Allier PL, Ziada KM, Mukherjee D, Wolski KE, Yadav JS, Brener SJ, Whitlow PL, Topol EJ and Ellis SG. Effect of uncoated stenting versus balloon angioplasty alone of long coronary (>20 mm) versus shorter narrowings on One- Year Event-Free survival, Am J Cardiol 91(5): 587-590, March 2003 61. Cho L, Roffi M, Mukherjee D, Bhatt DL, Bajzer C and Yadav JS. Superficial femoral artery occlusion: Nitinol stents achieve better flow and reduces the need for medications than balloon angioplasty alone J Inv Cardiology 15(4): 198-200, April 2003 62. Nallamothu BK Chetcuti S, Mukherjee D, Grossman PM, Kline-Rogers E, Werns S, Bates ER; Moscucci M. The Impact of Troponin-I Elevation After Percutaneous Coronary Intervention on Long-Term Survival. Am J Cardiol 91(10):1272-1274, May 2003. 15
  16. 16. 63. Mukherjee D and Eagle KA. Predictors of Missed Opportunities for Reperfusion in ST-segment-elevation Myocardial Infarction in the Global Registry of Acute Coronary Events (GRACE). Cardiovascular Reviews & Reports 24:249-250, May 2003 64. Mukherjee D and Eagle KA. What's new in the treatment of acute coronary syndromes? Emergency Medicine 35(5); 34 – 48, May 2003 65. Mukherjee D and Topol EJ. Pharmacogenomics in cardiovascular diseases. Curr Probl Cardiol 28(5):317-347, May 2003 66. Mukherjee D. CVD, Pharmacogenomics and tailored medical therapy. Geriatric Times 4(3), 13-14, June 2003 67. Mukherjee D and Eagle, KA. Perioperative Cardiac Assessment for Non-cardiac Surgery: Eight Steps to the Best Possible Outcome. Circulation 107: 2771 - 2774, June 2003 68. Mukherjee D. Renal Artery Stenosis: Who to Screen and How to Treat? ACC Curr J Rev 12(3): 70-75, June 2003 69. Mukherjee D and Eagle KA. Revised AHA/ACC Guidelines for the Management of non-ST segment Elevation Acute Coronary Syndromes: Highlights, Clinical Applications and Controversies. Current Cardiology Reports 5(4): 289-295, July 2003 70. Rajagopalan S, Pfenninger D, Kehrer C, Chakravarti A, Somers E, Pavlic R, Mukherjee D, Brook R, D’Alecy LG and Kaplan MJ. Increased ADMA and Endothelin 1 levels in secondary Raynaud’s phenomenon: Implications for vascular dysfunction and progression of disease. Arthritis Rheumatism 48 (7); 1992-2000, July 2003 71. Dey S and Mukherjee D. Clinical perspective on the role of anti-platelet therapy and statins in patients with vascular diseases. Curr Vasc Pharmacology 1(3); 329-333, September 2003 16
  17. 17. 72. Bates ER, Mukherjee D and Lau WC. Drug-Drug Interactions Involving Antiplatelet Agents. Eur Heart J 24 (19); 1707-1709, October 2003 73. Mukherjee D, Eagle KA, Smith DE, Kline-Rogers EM, Chetcuti S, Grossman PM, Nallamothu BK, O'Donnell M, DeFranco A, Maxwell-Eward A, McGinnity J,. Meengs WM, Patel K, and Moscucci M. Impact of Extra-Cardiac Vascular Disease on Acute Prognosis in Patients Undergoing Percutaneous Coronary Interventions: Data From the Blue Cross & Blue Shield of Michigan Consortium [BMC2] Am J Cardiol 92 (8), 972-974, October 2003 74. Nallamothu BK, Chetcuti S, Mukherjee D, Eagle, KA, Grossman P M, Giri K, McKechnie RS, Kline-Rogers E and Moscucci M. Long-term prognostic implication of extracardiac vascular disease in patients undergoing percutaneous coronary intervention Am J Cardiol 92 (8), 964-966, 2003 75. Mukherjee D and Topol EJ. Pharmaceutical Advertising versus Research Spending: Are Profits more important than Patients. Am Heart J 146, 563-564, October 2003 76. Rajagopalan S, Pfenninger D, Somers E, Kehrer C, Chakravarti A, Mukherjee D, Brook R and Kaplan MJ Effects of cilostazol in patients with Raynaud's syndrome. Am J Cardiol 92 (11), 1310-1315, December 2003 77. Mukherjee D and Eagle KA. Improving Quality of Care in the Real World – Efficacy vs Effectiveness? Am Heart J 146 (6), 946-947, December 2003 78. Yee KC, Mukherjee D, Smith DE, Kline-Rogers EM, Fang J, Mehta RH, Almanaseer Y, Akhras E, Cooper JV, and Eagle KA. Prognostic Significance of an Elevated Creatine Kinase in the Absence of an Elevated Troponin I During an Acute Coronary Syndrome Am J Cardiol 92 (12), 1442-1444, December 2003 17
  18. 18. 79. Mukherjee D, Hsu A, Moliterno DJ, Lincoff AM, Goormastic M and Topol EJ. Risk Factors for Premature Coronary Artery Disease and Determinants of Adverse Outcomes after Revascularization in Patients ≤ 40 years of Age Am J Cardiol 92 (12), 1465-1467, December 2003 80. Furman MI, Gore JM, Anderson FA, Budaj A, Goodman SG, Avezum A, López- Sendón J, Klein W, Mukherjee D, Eagle KA, Dabbous OH, Goldberg RJ. Elevated Leukocyte Count and Adverse Hospital Events in Patients with Acute Coronary Syndromes: Findings from the Global Registry of Acute Coronary Events (GRACE). Am Heart J 147 (1), 42-48, January 2004 81. Henke PK, Blackburn S, Proctor MC, Stevens J, Mukherjee D, Rajagopalan S, Upchurch GR, Stanley JC, and Eagle KA. Patients undergoing infrainguinal bypass for atherosclerotic vascular disease are underprescribed cardioprotective medications: Effect on graft patency, limb salvage, and mortality J Vasc Surg 39(2): 357-65, February 2004 82. Mukherjee D, Fang J, Chetcuti S, Moscucci M, Kline-Rogers E, and Eagle KA. Impact of Combination Evidence-based Medical Therapy on Mortality in Patients with Acute Coronary Syndromes Circulation 109(6): 745 – 749, February 2004 83. Chen MS, Bhatt DL, Mukherjee D, Chan AW, Roffi M, Kapadia SR, Ziada KM, Chew DP, Bajzer CT, and Yadav SJ. Safety of Simultaneous Bilateral Carotid Artery Stenting Cathet Cardiovasc Intervent 61:437–442, April 2004 84. Sarkar S, Leaman DW, Gupta S, Sil P, Young D, Morehead A, Mukherjee D, Ratliff N, Sun Y, Rayborn M, Hollyfield J, Sen S. Cardiac overexpression of myotrophin triggers myocardial hypertrophy and heart failure in transgenic mice. J Biol Chem 279 (19):20422-34, May 2004 85. Mukherjee D and Eagle KA. Improving Quality of Cardiovascular Care in the Real World – How can we Remove the Barriers Am J Managed Care 10(7): 471-472, July 2004 18
  19. 19. 86. Mukherjee D and Eagle KA. Treatment of the Post-Myocardial Infarction Patient Journal of Clinical Outcomes Management 11(7):436-443, July 2004 87. Mukherjee D and Eagle KA. Ischemia, Revascularization and Peri-operative Troponin Elevation after vascular Surgery. J Am Coll Cardiol 44(3): 576-578, August 2004 88. Mukherjee D, Fang J, Chetcuti S, Moscucci M, Kline-Rogers E and Eagle KA. Optimal Therapy for Acute Coronary Syndromes: The More the Better? Circulation 110: e52, August 2004 89. Fergus TS, Fazel R, Fang J, Chetcuti S, Smith DE, Kline-Rogers E, Munir K, Eagle KA, and Mukherjee D. Presentation, Management, and Outcomes of Diabetic Patients compared to Non-Diabetic Patients Admitted for Acute Coronary Syndromes HEART 90 (9):1051-1052, September 2004 90. Badr Al W, Mukherjee D, Kline-Rogers E, Mani O, Hussain S, Mehta R, Cooper JV, and Eagle KA. Clinical Association between Renal Insufficiency and Positive Troponin-I in Patients with Acute Coronary Syndrome Cardiology 102: 215-219, September 2004 91. Mukherjee D, Oz M, Prager R and Eagle KA. Elective Coronary Revascularization: An Iatrogenic Form of Acute Coronary Syndrome - How can Clinicians Reduce the Risks? Am Heart J 148(3): 371-377, September 2004 92. Mukherjee D. Role of Emboli protection devices in native coronary and saphenous vein graft percutaneous interventions. ACC Curr Jnl Rev 13(9), 32-35, September 2004 93. Mukherjee D. Current Clinical Perspectives on Myocardial Angiogenesis. Mol Cell Biochem 264 (1-2): 157-167, September 2004 19
  20. 20. 94. Saab FA, Eagle KA, Kline-Rogers E, Fang J, Otten R, and Mukherjee, D on behalf of the Michigan Cardiovascular Outcomes Research and Reporting Program [MCORRP] of the University of Michigan Cardiovascular Center. Comparison of Outcomes in Acute Coronary Syndrome in Patients Receiving Statins within 24 Hours of onset - Versus - At Later Times. American Journal of Cardiology 94(9), 1166-1168, November 2004 95. Mukherjee D and Bates ER. Current Role of Anti-thrombotic Agents in the Treatment of Acute Coronary Syndromes. Semin Thromb Hemost 30(6): 627-632, December 2004 96. Almanaseer Y, Mukherjee D, Kline-Rogers E, Mehta RH, Kesterson SK, Sonnad S, Rogers B, Smith D, Furney S, Ernst R, McCort J and Eagle KE. Implementation of the ACC/AHA Guidelines for Preoperative Cardiac Risk Assessment in a General Medicine Preoperative Clinic: Improving Efficiency and Preserving Outcomes Cardiology 103(1): 24-29, January 2005 97. Mukherjee D, Kline-Rogers E, Fang J, Munir K, and Eagle KA. Lack of Clopidogrel - CYP3A4 Statin Interaction in Patients with Acute Coronary Syndrome HEART 91:23–26, January 2005 98. Mukherjee D, Wainess RM, Dimick JB, Cowan JA Jr, Rajagopalan S, Chetcuti S, Grossman PM, and Upchurch Gr Jr. Variation in outcomes after Percutaneous Coronary Intervention in the United States and Predictors of Peri-procedural Mortality Cardiology 103(3):143-147, February 2005 99. Fazel R, Fang J, Kline-Rogers E, Smith DE, Eagle KA, and Mukherjee D. Prognostic Value of Elevated Biomarkers in Diabetic Compared to Non-Diabetic Patients Admitted for Acute Coronary Syndromes HEART 91(3):388-90, March 2005 100. Mukherjee D, Fang J, Kline-Rogers E, Otten R and Eagle KA. Impact of Combination Evidence-based Medical Therapy in Patients with Acute Coronary Syndromes in Various TIMI Risk Groups HEART 91(3):381-382, March 2005 20
  21. 21. 101. Evangelista A, Mukherjee D, Mehta RH, O’Gara PT, Fattori R, Cooper JV, Smith DE, Oh JK, Hutchison S, Sechtem U, Isselbacher EM, Nienaber CA, Pape LA, Eagle KA for the IRAD* Investigators. Acute Intramural Hematoma of the Aorta: A Mystery in Evolution Circulation ;111:1063-1070, March 1st 2005 102. Mukherjee D, Meier D and Eagle KA. A 40-year old female with exertional angina J Invasive Cardiology 17(3): 185-186, March 2005 103. Mukherjee D. Percutaneous coronary intervention versus coronary artery bypass grafting in diabetic patients. Cardiology Clinics of North America 23(2):185-91, May 2005 104. Armstrong D, Kline-Rogers E, Jani SM, Goldman EB, Fang J, Mukherjee D, Nallamothu BK, Eagle KA. Potential Impact of the HIPAA Privacy Rule on Data Collection in a Registry of Patients With Acute Coronary Syndrome Arch Intern Med 165:1125-1129, May 2005 105. Mukherjee D and eagle KA. Aortic dissection – an Update. Curr Prob in Cardiology 30(6): 281-326, June 2005 106. Mukherjee D. Optimizing Management of Patients with Coronary Artery Disease - How do we get there? Eur Heart J 26(12): 1147 – 1149, June 2005 107. Mukherjee D, Munir K, Hirsch AT, Chetcuti S, Grossman PM, Rajagopalan SR, Nallamothu BK, Moscucci M, Henke P, Kassab E, Sohal C, Riba A Person D, Luciano AE, DeGregorio M, Patel K, Rutkowski KC, and Eagle KA. Development of a Multicenter Peripheral Arterial Interventional Database: The Peripheral Vascular Disease Quality Improvement Initiative (PVD-QI2). American Heart Journal 149(6):1003-1008, June 2005 21
  22. 22. 108. Nallamothu B, Saint M, Saint S and Mukherjee D. Double Jeopardy. New England J Med 353:75-80, July 2005 109. Ziada KM, Yadav JS, Mukherjee D, Lauer MS, Bhatt DL, Kapadia S, Roffi M, Vora N, Tiong I, and Bajzer C. Management of Severe Cardiac and Carotid Disease: Favorable Outcomes of Carotid Stenting Followed by Open Heart Surgery Versus Combined Carotid Endarterectomy and Open Heart Surgery. Am J Cardiol 96 (4), 519-523, August 2005 110. Cho L and Mukherjee D. Use of Hormone Replacement Therapy for the Prevention of Cardiovascular Disease Events: A meta-analysis of randomized trials. Cardiology 104(3):143-147, August 2005 111. Keast RK, Eagle KA, Goldstein-Dunn J, Cox D, Michalak CG, Chetcuti S, Grossman PM, Mukherjee D, Larin LR, Fetyko S, Denton TA and Moscucci M. Shelf- Price Agreements: The Next Frontier in Competitive Bidding for Coronary Intervention Supplies Journal of Cardiovascular Management 16(3):27-30, September 2005 112. Dumasia R, Eagle KA, Kline-Rogers E, May N, Cho L and Mukherjee D. Role of PPAR- γ Agonist Thiazolidinediones in Treatment of Pre-Diabetic and Diabetic Individuals: A Cardiovascular Perspective. Current Drug Targets - Cardiovascular & Haematological Disorders, 5(5):377-86, October 2005 113. Otten R, Kline-Rogers E, Meier D, Dumasia R, Fang J, May N, Resin Y, Armstrong DF, Saab F, Petrina M, Eagle KA, and Mukherjee D. Impact of Prediabetic state on Clinical Outcomes in patients with Acute Coronary Syndromes. HEART 91:1466-1468, November 2005 114. Mukherjee D, Topol EJ, Bertrand ME, Kristensen SD, Herrmann HC, Neumann FJ, Yakubov SJ, Bassand JP, McClure RR, Stone GW, Ardissino D, and Moliterno DJ for the TARGET Investigators. Mortality at 1 year for the direct comparison of tirofiban and abciximab during percutaneous coronary revascularization: Do Tirofiban and ReoPro 22
  23. 23. Give Similar Efficacy Outcomes at Trial (TARGET) 1-Year Follow-Up. Eur Heart J 26(23):2524-8, December 2005 115. Tsai TT, Nallamothu BK, Mukherjee D, Rubenfire M, Fang J, Chan P, Kline- Rogers E, Patel A, Armstrong DF, Eagle KA and Goldberg AD. Effect of Statin Use in Patients with Acute Coronary Syndromes and a Serum Low-Density Lipoprotein ≤ 80 mg/dl. Am J Cardiol 96(11):1491-3, December 2005 116. Mukherjee D, Evangelista A, Nienaber CA, Sechtem U, Suzuki T, Trimarchi S, Llovet A, Myrmel T, O'Gara PT, Fang J, Cooper JV, Oh JK, Januzzi JL, Hutchison S, Fattori R, Pape LA, Isselbacher EM, and Eagle KA. Implications of Periaortic Hematoma in Patients with Acute Aortic Dissection: (From the International Registry of Aortic Dissection) Am J Cardiol 96(12):1734-8, December 2005 117. Mukherjee D. Commentary 2 (Role and appropriate timing of invasive evaluation in patients with unstable angina and NSTEMI. Evid Based Cardiovasc Med. 9(4):292-3, December 2005 118. Mukherjee D, Topol EJ, Moliterno DJ, Brennan DM, Ziada K, Cho L, and Steinhubl SR. Extra-Cardiac Vascular Disease and Effectiveness of Sustained Clopidogrel Therapy HEART 92: 49 – 51, January 2006 119. Ramanathan PK, Eagle KA, Fang J, Kline-Rogers EM, Land B, Otten RF, Resin Y, and Mukherjee D. Smoking Cessation in Patients with Acute Coronary Syndrome. Indian Heart J; 58: 47-51, February 2006 120. Mukherjee D and Moliterno DJ. Brachytherapy for In-Stent Restenosis - A Distant Second Choice to Drug-eluting Stent Placement. JAMA 295:1307-1309, March 2006 121. Froehlich JB, Mukherjee D, Avezum A, Budaj A, Kline-Rogers E, López-Sendón J, Agnelli G, Allegrone J, Eagle, MD KA, Mehta RH and Goldberg RJ. Association of Peripheral Artery Disease With Treatment and Outcomes in Acute Coronary Syndromes. 23
  24. 24. The Global Registry of Acute Coronary Events (GRACE). Am Heart J 151:1130-1135, May 2006 122. Shishehbor MH, Topol EJ, Mukherjee D, Hu T, Cohen DJ, Stone GW, McClure R, Roffi M, and Moliterno DJ. Clinical Outcome of Multivessel Coronary Intervention in the Contemporary Percutaneous Revascularization Era. Am J Cardiol; 97:1585–1590, June 2006 123. Cho L and Mukherjee D. Basic Cerebral Anatomy: The Intracranial and Extracranial Vessels Catheter Cardiovasc Interv 68(1):104-111, June 2006 124. Das P, Ziada K, Steinhubl SR, Moliterno DJ, Hamdalla H, Jozic J and Mukherjee D. Heparin-induced Thrombocytopenia and Cardiovascular diseases. Am Heart J 152(1):19-26, July 2006 125. Mukherjee D. Continuous Quality Improvement Initiatives in the Cardiac Catheterization Laboratory – Can We have Our Cake and Eat It Too? Am J Managed care 12(8):429-30, August 2006 126. Saab FA, Petrina M, Kline-Rogers E, Fang J, Otten R, Mukherjee D and Eagle KA. Early Statin Therapy in Elderly Patients Presenting with Acute Coronary Syndrome Causing Less Heart Failure. Indian Heart Journal: 321–324 August 2006 127. Das P, Moliterno DJ, Charnigo R, Mukherjee D, Sneed D, Steinhubl SR, Booth DC, Ziada KM. Impact of Drug-Eluting Stents on Outcomes of Patients with End-Stage Renal Disease Undergoing Percutaneous Coronary Revascularization. J Inv Cardiology 18(9):405-8, Sept 2006 128. Mukherjee D. Does a coxib-associated thrombotic risk limit the clinical use of the compounds as analgesic anti-inflammatory drugs? Thrombosis and Haemostasis 96(4):407-12, October 2006 24
  25. 25. 129. Rajagopalan S, Dellegrottaglie S, Furniss AL, Gillespie BW; Satayathum S, Lameire N, Saito A, Akiba T, Jadoul M, Ginsberg N, Keen M, Port FK, Mukherjee D, Saran R. Peripheral Arterial Disease in Patients with End-Stage Renal Disease - Observations from the Dialysis Outcomes and Practice Patterns Study (DOPPS) Circulation114:1914-1922, October 2006 130. Harada RK, Eagle KA, Kline-Rogers EM, Fang J, Smith D, and Mukherjee D. Low Utilization of Secondary Preventive Medications and its Potential Impact in Patients with Chronic Kidney Disease and Acute Coronary Syndromes. Indian Heart Journal 2006; 58: 223–230, November 2006 131. Mukherjee D and Moliterno DJ. The Timely Coupling of Mechanical Revascularization following Thrombolysis for Myocardial Infarction. Cardiology 107:337-339, January 2007 132. Mardikar HM and Mukherjee D. Current Endovascular Treatment of Peripheral Arterial Disease. Prog Cardiovasc Nursing 22:31–37, March 2007 133. Latchamsetty R, Fang J, Kline-Rogers E, Mukherjee D, Otten RF, LaBounty TM, Emery MS, Eagle KA, Froehlich JB. Prognostic Value of Transient and Sustained Rise of In-hospital Creatinine on Outcomes of Patients Admitted with Acute Coronary Syndrome. Am J Cardiol 99:939 –942, April 2007 134. Mukherjee D and Roffi M. Current Strategies With High Dose Tirofiban Expert Opinion on Drug Metabolism and Toxicology 3(2):275-280, April 2007 135. Mukherjee D. Designing and Performing Large Multicenter Randomized Clinical Trials in India: What do we need? Indian Heart J; 59: 113-115, April 2007 25
  26. 26. 136. Roffi M, Brandle M, Robbins MA, and Mukherjee D. Current Perspectives on Coronary Revascularization in the Diabetic Patient. Indian Heart J; 59: 124-136, April 2007 137. Bhatt DL, Chew DP, Grines C, Mukherjee D, Leesar M, Gilchrist IC, Corbelli JC, Blankenship JC, Eres A, Steinhubl S, Tan WA, Resar JR, AlMahameed A, Abdel-Latif A, Tang HW, Brennan D, McErlean E, Hazen SL, Topol EJ. Peroxisome proliferator- activated receptor gamma agonists for the Prevention of Adverse events following percutaneous coronary Revascularization--results of the PPAR study. American Heart Journal 154(1):137-43, July 2007 138. Mukherjee D, Eagle KA, Kline-Rogers E, Feldman LJ, Juliard JM, Agnelli G, Budaj A, Avezum A, Allegrone J, FitzGerald G, Steg PG, on behalf of the GRACE Investigators. Impact of Prior Peripheral Arterial Disease and Stroke on Outcomes of Acute Coronary Syndromes and Effect of Evidence-Based Therapies (from the Global Registry of Acute Coronary Events) Am J Cardiol 100(1):1-6, July 2007 139. Mardikar HM, Hiremath MS, Moliterno DJ, Mathew R, Arora R, Deo D, Hiremath JS, Deshpande NV, Khan A, Joseph J and Mukherjee D. Optimal Platelet Inhibition in Patients undergoing PCI: Data from the Multicenter Registry of High-Risk Percutaneous Coronary Intervention and Adequate Platelet Inhibition (MR PCI) Study. American Heart Journal 154(2):344.e1-5, August 2007 140. Bhatheja R and Mukherjee D. Acute Coronary Syndromes: Non ST Segment Elevation Myocardial Infarction. Critical Care Clinics of North America 23(4); 709-735, October 2007 141. Mukherjee D and Eagle KA. The Use of Antithrombotics for Acute Coronary Syndromes in the Emergency Department: Considerations and Impact Progress in Cardiovascular Diseases, 50, (3): 167-180, November – December 2007 26
  27. 27. 142. Mukherjee D and Pineda G. Extracranial Vertebral Artery Intervention. J Interv Cardiol 20(6):409-16, December 2007 143. Mukherjee D and Moliterno DJ. Effectiveness of Drug-Eluting Stents in Real- World Patients. JAMA 299(4):454-455, January 2008 144. Roffi M and Mukherjee D. Platelet glycoprotein IIb/IIIa receptor inhibitors – End of an Era? Eur Heart J 29: 429-431, February 2008 145. Mukherjee D. Improving Adherence to Medications - Can We Make This Horse Drink? Am Heart J 155: 589-590, April 2008 146. Mukherjee D and Roffi M. Glycoprotein IIb/IIIa Receptor Inhibitors in 2008: Do They Still Have a Role? J Interv cardiology 21(2):118-21, April 2008 147. Mukherjee D. Nonsteroidal Anti-Inflammatory Drugs and the Heart: What Is the Danger? Congest Heart Fail 14(2): 75-82, April 2008 148. Kim JS, Mukherjee D. Current status of carotid stenting. Curr Vasc Pharmacol 6(2): 143-7, April 2008 149. Mukherjee D. Antithrombotic Agents for Acute Coronary Syndromes. Cardiovascular and Hematological Agents in Medicinal Chemistry 6 (2):130-141, April 2008 150. Mukherjee D. Optimal Treatment for In-stent Restenosis after BMS – DES, Coated Balloon or Scalpel? Eur Heart J 29, 1595–1596, July 2008 151. Mukherjee D. Vertebral Artery Interventions. Am Heart Hosp J (in press) 152. Mardikar H, Deo D, Deshpande N, Mardikar M, Ghosh A, Munot K, Steinhubl S, and Mukherjee D. Variability in platelet response to single daily dose of 150 mg enteric coated aspirin in high risk population. J Assoc Physicians India (in press) 27
  28. 28. 153. Shah A, Banerjee T and Mukherjee D. Coronary, peripheral and cerebrovascular disease: a complex relationship. Herz (in press) 154. Mark DB, Berman DS, Lauer MS, Budoff MJ, Miller JM, Carr JJ, Morin RL, Gerber TC, Mukherjee D, Hecht HS, Poon M, Hodgson JM, Rubin GD, Hlatky MA Schwartz RS. ACCF/AHA/SCAI/SCCT/SAIP/ACR Clinical Expert Consensus Document on CT Angiography. J Am Coll Cardiol (in press) 155. Mukherjee D. Peripheral and cerebrovascular disease. Best Practice & Research: Clinical Endocrinology & Metabolism (in press) 156. Mukherjee D. Unraveling the Genetic Predisposition for Aortic Aneurysms - Is it Time for Tailored Medicine. Am J Hypertens (in press) Abstracts: 1. Mukherjee D and Sen S. Collagen phenotypes during development and regression of myocardial hypertrophy in spontaneously hypertensive rats. Circulation 80(4): II -595, 1989 (Presented at the 62nd Scientific session of the American Heart Association). 2. Mukherjee D and Sen S. In Vitro transcriptional enhancement of myosin and connexin (gap junction protein) by myotrophin. Circulation 82(4): III - 231, 1990 (Presented at the 63rd Scientific session of the American Heart Association). 3. Sen S, Sil P and Mukherjee D. Quantification of myotrophin from spontaneously hypertensive rat heart. Circulation 84(4): II - 397, 1991 (Presented at the 64th Scientific session of the American Heart Association). 28
  29. 29. 4. Mukherjee D, McTiernan CF and Sen S. Effect of myotrophin on induction of proto - oncogenes, ANF and contractile element transcript levels. Circulation 86(4) I - 626, 1992 (Presented at the 65th Scientific session of the American Heart Association). 5. Mukherjee D, Thekkumkara T, Sen G and Sen S. Ontogeny of myotrophin mRNA in spontaneously hypertensive rat (SHR) hearts. Circulation 86(4) I - 96, 1992 (Presented at the 65th Scientific session of the American Heart Association). 6. Silver MJ, Chetcuti S, Mukherjee D, Malycky JL, Tomei DL, Umansky S, and Nicolini FA. Use of a novel anti-apoptotic agent (LXR017) reduces infarct size following ischemia-reperfusion in the canine myocardium. J Am Coll Cardiol 31(2) Suppl A, 66A, 1998 (Presented at the 47th Annual Scientific Session of the American College of Cardiology). 7. Steinhubl SR, Lauer MS, Mukherjee D, Moliterno DJ, Ellis SG, and Topol EJ. Pretreatment with ticlopidine reduces non-q wave myocardial infarctions following intracoronary stenting. J Am Coll Cardiol 31(2) Suppl A, 100A, 1998 (Presented at the 47th Annual Scientific Session of the American College of Cardiology). 8. Wong J, Mukherjee D, Porter T, Young D, Sen S and Thomas J. Ultrasound enhances PESDA linked oligonucleotide deposition into myocardial tissue. J Am Soc Echo 11(5) RC, 1998 (Presented at the 9th Annual Scientific Session of the American Society of Echocardiography). 9. Wong J, Mukherjee D, Porter T, Young D, Sen S and Thomas J. Ultrasound power affects uptake of PESDA linked oligonucleotide deposition into myocardial tissue. Circulation 98(17) I - 503, 1998 (Presented at the 71st Scientific session of the American Heart Association). 10. Mukherjee D, Wong J, Griffin BP, Ellis SG, Porter T, Sen S, and Thomas JD. Ten fold augmentation of myocardial uptake of vascular endothelial growth factor with ultrasound after systemic administration. . J Am Coll Cardiol 33(2) Suppl A, 4A, 1999 29
  30. 30. (Presented at the 48th Scientific session of the American College of Cardiology as a Young Investigator Award Finalist). 11. Mukherjee D, Wong J, Griffin BP, Ellis SG, Porter T, Vince DG, and Thomas JD. Endothelial and Smooth Muscle Cell Migration Induced by Vascular Endothelial Growth Factor with Ultrasound after Systemic Administration. J Am Coll Cardiol 33(2) Suppl A, 408A, 1999 (Presented at the 48th Scientific session of the American College of Cardiology). 12. Mukherjee D, Olano A, Nader S, Garcia M, and Griffin BP. Improvement in right ventricular systolic function after tricuspid valve surgery for isolated severe tricuspid regurgitation. J Am Soc Echo 11(5) RC, 1999 (Presented at the 10th Annual Scientific Session of the American Society of Echocardiography). 13. Mukherjee D, Wang K, Ellis SG, Silver M, Zhou X, Nimrod R, Topol EJ, and Lincoff AM. Selective Inhibition of Factor Xa is more Efficient than Heparin at Facilitating Coronary Thrombolysis in a Canine Model. J Am Coll Cardiol ; 35(2): Suppl A, 373A, 2000 (Presented at the 49th Scientific session of the American College of Cardiology). 14. Mukherjee D, Wong J, Griffin BP, Ellis SG, Sen S, Porter T, and Thomas JD. Ultrasound Power Increases Myocardial Vascular Endothelial Growth Factor Uptake in a Dose Dependent Manner. J Am Coll Cardiol ; 35(2): Suppl A, 494A, 2000 (Presented at the 49th Scientific session of the American College of Cardiology). 15. Mukherjee D, Reginelli JP, Chew DP, Schneider JP, Raymond R, Whitlow PL, Franco I, Topol EJ, and Ellis SG. A Potential New Indication for Thienopyridine ADP- receptor Antagonists: In-stent Restenosis. J Am Coll Cardiol ; 35(2): Suppl A, 84A, 2000 (Presented at the 49th Scientific session of the American College of Cardiology). 16. Mukherjee D, Mahaffey KW, Sparapani R, Dyke C, Roe MT, Moliterno DJ, Harrington R, Califf R and Topol EJ. The promise of combined LMW heparin and 30
  31. 31. Platelet glycoprotein IIb/IIIa inhibition – Results from PARAGON B. Circulation 102(18), II - 591, 2000 (Presented at the 73rd Scientific session of the American Heart Association). 17. Mukherjee D, Reginelli JP, Moliterno DJ, Yadav SJ, Schneider JP, Raymond R, Whitlow PL, Franco I, and Ellis SG. Mortality reduction with abciximab for in-stent restenosis Circulation 102(18), II - 666, 2000 (Presented at the 73rd Scientific session of the American Heart Association). 18. Cura FA, Kapadia SR, Ziada KM, Mukherjee D, Wolski KE, Bhatt DL, Yadav JS, Whitlow PL Brener SJ, and Ellis SG. Lesion length and stent caution: Lessons from randomized trials. Circulation 102(18), II - 387, 2000 (Presented at the 73rd Scientific session of the American Heart Association). 19. Roffi M, Cura FA, Kapadia SR, Mukherjee D, Bhatt DL, Chew D, Robbins MA, Albirini A, Wolski KE, and Ellis SG. Extending the temporal window for repeat target vessel revascularization: Stenting loses ground versus balloon angioplasty after six months. Circulation 102(18), II - 667, 2000 (Presented at the 73rd Scientific session of the American Heart Association). 20. Bhatt DL, Mukherjee D, Roffi M, Kapadia SR, Ziada KM, Chew DP, and Yadav JS. Is Simultaneous Bilateral Carotid Artery Stenting Safe? J Am Coll Cardiol; 37(2): Suppl A, 50A, 2001 (Presented at the 50th Scientific session of the American College of Cardiology). 21. Roffi M, Chew DP, Mukherjee D, Bhatt DL, Robbins MA, Topol EJ. Glycoprotein IIb/IIIa inhibitors in the medical management of unstable ischemic syndromes without persistent ST-segment elevation: a meta-analysis of the randomized trials. J Am Coll Cardiol; 37(2): Suppl A, 365A, 2001 (Presented at the 50th Scientific session of the American College of Cardiology). 31
  32. 32. 22. Roffi M, Bhatt DL, Mukherjee D, Chew DP, Ziada KM, Prosper DM, Ellis SG, Topol EJ. Stents and glycoprotein IIb/IIIa blockade have no salutary effect on 30-day outcome following percutaneous interventions of coronary bypass grafts. J Am Coll Cardiol; 37(2): Suppl A, 68A, 2001 (Presented at the 50th Scientific session of the American College of Cardiology). 23. Roffi M, Chan A, Chew DP, Robbins MA, Mukherjee D, Bhatt DL, Albirini A, Cho L, Agah R, Topol EJ, Ellis SG. Stents and glycoprotein IIb/IIIa inhibitors do not improve 30-day outcome in bypass graft percutaneous interventions: a retrospective registry-based analysis. J Am Coll Cardiol; 37(2): Suppl A, 77A, 2001 (Presented at the 50 th Scientific session of the American College of Cardiology). 24. Roffi M, Mukherjee D, Bhatt DL, Chew DP, Ziada KM, Prosper DM, Ellis SG, Topol EJ. Percutaneous coronary interventions of coronary bypass grafts have doubled major adverse events. J Am Coll Cardiol; 37(2): Suppl A, 6A, 2001 (Presented at the 50th Scientific session of the American College of Cardiology). 25. Robbins MA, Chew DP, Bhatt DL, Mukherjee D, Roffi M, Schneider JP, Topol EJ, Ellis SG. ADP-antagonists therapy added to aspirin prior to coronary intervention markedly attenuates the risk associated with baseline CRP status. J Am Coll Cardiol; 37(2): Suppl A, 28A, 2001 (Presented at the 50th Scientific session of the American College of Cardiology). 26. Chew DP, Robbins MA, Bhatt DL, Mukherjee D, Roffi M, Topol EJ, Ellis SG. CRP provides prognostic value in addition to ACC/AHA lesion score following PCI. J Am Coll Cardiol; 37(2): Suppl A, 22A, 2001 (Presented at the 50th Scientific session of the American College of Cardiology). 27. Kapadia S, Ziada KM, Crowe TD, Mukherjee D, Hobbs RE, Nissen SE, Tuzcu EM. Total plaque Burden in early atherosclerosis: Can it be predicted by the most severe lesion? J Am Coll Cardiol; 37(2): Suppl A, 63A, 2001 (Presented at the 50 th Scientific session of the American College of Cardiology). 32
  33. 33. 28. Mukherjee D, Bhatt DL, Roffi M, Ziada KM, Hughes K, Bajzer C, Krieger D, Whitlow P and Yadav JS. Treatment of Symptomatic Vertebral Artery Stenosis with Angioplasty and Stenting. (Presented at the International Course on carotid Angioplasty, Frankfurt/Offenbach, Germany, March 1-3, 2001). 29. Mukherjee D, Kalahasti V, Bhatt DL, Roffi M, Ziada KM, Hughes K, Bajzer C, Krieger D, Whitlow P and Yadav JS. Self-expanding stents for carotid intervention: Comparison of Nitinol versus stainless steel stents. (Presented at the International Course on carotid Angioplasty, Frankfurt/Offenbach, Germany, March 1-3, 2001). 30. Roffi M, Bhatt DL, Mukherjee D, Chew DP, Ziada KM, Prosper DM, Ellis SG, Topol EJ. Effects of stenting and glycoprotein IIb/IIIa on bypass graft interventions: Pooled analysis of five randomized glycoprotein IIb/IIIa trials. (Presented at the Swiss Society of Cardiology Meeting, March 23 –30, 2001). Kardiovaskulare Medizin; 4: Suppl 3, 2001. 31. Bhatt DL, Kapadia SR, Chew DP, Mukherjee D, Ziada KM, Topol EJ, Yadav SJ. Dual antiplatelet therapy with clopidogrel and aspirin after carotid artery stenting. Eur Heart J; 22 (Suppl), p 634, 2001 (Presented at the 23rd Annual Congress of the European Society of Cardiology 2001). 32. Zhou Z, Mukherjee D, Wang K, Zhou X, Tarakji K, Penn MS, Ellis SG. Intravenous Infusion of Vascular Endothelial Growth Factor (VEGF) With Ultrasound Energy and Echo Contrast Agent Improves Myocardial Blood Flow and Decreases Infarct Size in a Canine Model of Chronic Myocardial Ischemia. Am J Cardiol 88 (5) Suppl 1, p 86G [Presented at the Transcatheter Cardiovascular Therapeutics (TCT 2001) Meetings]. 33. Chan AW, Quinn MJ, Mukherjee D, Moliterno DJ, and Ellis SG. Striking mortality benefit of β-blockade after successful elective percutaneous coronary intervention 33
  34. 34. Circulation 104(17), II - 711, 2001 (Presented at the 74th Scientific session of the American Heart Association). 34. Mukherjee D, Bhatt DL, Robbins M, Roffi M, Cho L, Reginelli J, Bajzer C, Navarro F, Yadav JS. Renal Artery end-diastolic velocity and renal artery resistance index predicts outcome after renal artery stenting. Circulation 104(17), II–584, 2001 (Presented at the 74th Scientific session of the American Heart Association). 35. Roffi M, Chew DP, Mukherjee D, Bhatt DL, Robbins MA, White JA, Heeschen C, Hamm CW, Theroux P, Topol EJ. Glycoprotein IIb/IIIa inhibitors reduce mortality in diabetic patients with unstable ischemic syndromes. Circulation 104(17), II - 782, 2001 (Presented at the 74th Scientific session of the American Heart Association). 36. Roffi M, Mukherjee D, Chew DP, Robbins MA, Cho L, Agah R, Chan AW, Quinn MJ, Ellis SG. Procedural success and outcome of percutaneous coronary intervention of arterial bypass grafts. Circulation 104(17), II - 776, 2001 (Presented at the 74th Scientific session of the American Heart Association). 37. Roffi M, Mukherjee D, Chan AW, Yadav SJ. Can ultrasound accurately predict restenosis after carotid artery stenting? Circulation 104(17), II - 583, 2001 (Presented at the 74th Scientific session of the American Heart Association). 38. Abou-Chebl A, Reginelli J, Mukherjee D, Bhatt D, Bajzer C, and Yadav J. Cerebral hyperperfusion and intracranial hemorrhage following internal carotid artery stenting. J Am Coll Cardiol; 39(5): Suppl A, 68A, 2002 (Presented at the 51st Scientific session of the American College of Cardiology). 39. Chan A, Bhatt DL, Wilkoff BL, Roffi M, Mukherjee D, Gray B, Bajzer C, and Yadav SJ. Percutaneous treatment for pacemaker lead related SVC syndrome. J Am Coll Cardiol; 39(5): Suppl A, 99A, 2002 (Presented at the 51st Scientific session of the American College of Cardiology). 34
  35. 35. 40. Mukherjee D, Gurm H, Tang WH, Roffi M Wolski K, Moliterno DJ, Guetta V, Ardissinio D, Bode C, Steg G, Lincoff AM, and Topol EJ. Improved Outcome of Acute ST-segment Elevation Myocardial Infarction in Patients With Prior Coronary Artery Bypass Surgery Treated with Combination Reduced Fibrinolytic Therapy and Platelet Glycoprotein IIb/IIIa Inhibition. J Am Coll Cardiol; 39(5): Suppl A, 293A, 2002 (Presented at the 51st Scientific session of the American College of Cardiology). 41. Zhou Z, Mukherjee D, Wang K, Zhou X, Tarakji K, Ellis K, Chan A, Penn MS, Ostensen J, Thomas JD, Garcia M, Topol EJ, and Ellis SG. Induction of Angiogenesis in a Canine Model of Chronic Myocardial Ischemia With Intravenous Infusion of Vascular Endothelial Growth Factor (VEGF) Combined With Ultrasound Energy and Echo Contrast Agent. J Am Coll Cardiol; 39(5): Suppl A, 396A, 2002 (Presented at the 51st Scientific session of the American College of Cardiology). 42. Sheikh MA, Navarro F, Mukherjee D, Bajzer C, Yadav J. Percutaneous Intervention for Occlusive Subclavian Artery Disease. J Am Coll Cardiol; 39(5): Suppl A, 6A, 2002 (Presented at the 51st Scientific session of the American College of Cardiology). 43. Kapadia SR, Ziada KM, Mukherjee D, Nissen SE, and Tuzcu EM. Limitation of Intravascular Ultrasound in Determining Artery Size: Role of Distension Pressure. J Am Coll Cardiol; 39(5): Suppl A, 12A, 2002 (Presented at the 51st Scientific session of the American College of Cardiology). 44. Chan AW, Roffi M, Mukherjee D, Bajzer C, Abou-Chebl A, Ciezki J, Bhatt DL, Ghaffari S, and Yadav J. Bilateral carotid brachytherapy for in-stent restenosis (Presented at the 13th annual meeting of the Society for Vascular Medicine and Biology Annual Meeting, Boston, MA). 45. Mukherjee D, Smith D, Share D, Kline-Rogers E, Eagle KA, Chetcuti S, Grossman P Michael, and Moscucci M. Significantly higher mortality in patients with IDDM compared to patients with NIDDM and non-diabetics undergoing coronary interventions. 35
  36. 36. Eur Heart J 23: Suppl, pp 610, 2002 (Presented at the European society of Cardiology Congress, September 2002, Berlin, Germany). 46. Mukherjee D, Smith D, Chetcuti S, Share D, Kline-Rogers E, Eagle KA, Grossman P Michael, Moscucci, M. Lack of benefit of intravenous GP IIb/IIIa inhibitors in diabetic patients undergoing PCI is explained by differences in baseline characteristics. Eur Heart J 23: Suppl, pp 317, 2002 (Presented at the European society of Cardiology Congress, September 2002, Berlin, Germany). 47. Mukherjee D, Smith D, Kline-Rogers E, Chetcuti S, Eagle KA, Grossman P Michael, Share D, Moscucci M. Significant mortality benefit of prior beta-blocker use in diabetic patients undergoing coronary intervention. Eur Heart J 23: Suppl, pp 317, 2002 (Presented at the European society of Cardiology Congress, September 2002, Berlin, Germany). 48. Nallamothu BK, Chetcuti S, Mukherjee D, Grossman P M, Werns S, Bates E, and Moscucci M. Impact of serum troponin-I elevation on long term survival following percutaneous coronary intervention. Eur Heart J 23: Suppl, pp 155, 2002 (Presented at the European society of Cardiology Congress, September 2002, Berlin, Germany). 49. Mukherjee D, Eagle KA, Smith DE, Kline-Rogers EM, O'Donnell M, De Franco A, Maxwell-Eward A, McGinnity J, Meengs WM, Patel K, Moscucci M. Prognostic Implications of Extra-Cardiac Vascular Disease in Patients Undergoing Coronary Interventions: Insights From the Blue Cross & Blue shield of Michigan Consortium [BMC2] Circulation 106(19), II - 492, 2002 (Presented at the 75th Scientific session of the American Heart Association). 50. Mukherjee D, Froehlich JB, Avezum A, Lopez-Sendon J, Kline-Rogers EM, Johnson J, Mehta RH. Prognostic Implications of Peripheral Vascular Disease in Patients with Acute Coronary Syndromes: Insights From the Global Registry of Acute Coronary Events [GRACE] Circulation 106(19), II - 678, 2002 (Presented at the 75th Scientific session of the American Heart Association). 36
  37. 37. 51. Mukherjee D, Dey S, Lingam P, Chetcuti S, Grossman PM, Moscucci M, Rajagopalan S, Luciano AE, Eagle KA. Predictors of Clinical Outcome in Patients Undergoing Peripheral Vascular Interventions: Insights From the University of Michigan Peripheral Vascular Disease Quality Improvement Initiative (PVD-QI2) J Am Coll Cardiol; 41(6): Suppl A, 75A, 2003 (Presented at the 52nd Scientific session of the American College of Cardiology). 52. Chetcuti S, Grossman PM, Mukherjee D, Lingam P, Kline-Rogers E, Share D, Moscucci M. Improving Outcome of Percutaneous Coronary Intervention Through Application of Guidelines and Benchmarking: Reduction of Blood Transfusion as a Model J Am Coll Cardiol; 41(6): Suppl A, 527A, 2003 (Presented at the 52nd Scientific session of the American College of Cardiology). 53. Froehlich JB, Mukherjee D, Avezum A, Budaj A, Kline-Rogers EM, Lopez-Sendon J, Johnson J, Eagle KA, Mehta RM. Quality of Care for Patients With Peripheral Vascular Disease (PVD) During Acute Coronary Syndromes (ACS): Insights From the Global Registry of Acute Coronary Events (GRACE). J Am Coll Cardiol; 41(6): Suppl A, 252A, 2003 (Presented at the 52nd Scientific session of the American College of Cardiology). 54. Rajagopalan S, Pfenninger D, Kehrer C, Somers E, Chakraborti A, McCune WJ, Mukherjee D, Brook RD, Kaplan M. Cilostazol in Raynaud’s Disease-A Double-Blind Placebo Controlled Clinical Trial. J Am Coll Cardiol; 41(6): Suppl A, 304A, 2003 (Presented at the 52nd Scientific session of the American College of Cardiology). 55. Moscucci M, Smith D, Mukherjee D, Montoye C, O'Donnell MJ, DeFranco AC, Meengs WL, Maxwell-Eward A, McGinnity JG, Patel K, Share D, For The Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2). Relationship Between Time Of Day/Day Of Week And Outcomes In Patients Undergoing Primary PCI For Acute Myocardial Infarction. J Am Coll Cardiol; 41(6): Suppl A, 541A, 2003 (Presented at the 52nd Scientific session of the American College of Cardiology). 37
  38. 38. 56. Zhou X, Mukherjee D, Zhou Z, Lincoff AM, Wang K . A combination of a selective factor Xa inhibitor and full dose tPA is more effective than heparin and full dose tPA at facilitating coronary thrombolysis in a canine model. Eur Heart J 23: Suppl, pp 317, 2003 (Presented at the European society of Cardiology Congress, September 2003, Vienna, Austria). 57. Mukherjee D, Eagle KA, Smith DE, Kline-Rogers E, Lins S, Draus C, Share D, Chetcuti S, Grossman PM, and Moscucci M. A Simple Risk Score for Predicting Mortality in Diabetic Patients Undergoing Percutaneous Coronary Intervention Circulation 108(17), IV-717, 2003 (Presented at the 76th Scientific session of the American Heart Association). 58. Fox KA, Gore JM, Montalescot G, Mukherjee D, Gowda N, Steg G Ph, for the GRACE Investigators. Impact of Insulin Treatment on Patients with ST-Segment Elevation Myocardial Infarction. The Global Registry of Acute Coronary Events Circulation 108(17), IV-746, 2003 (Presented at the 76th Scientific session of the American Heart Association). 59. Chetcuti SJ, Mukherjee D, Smith DE, Grossman PM, Bates ER, Duvernoy CJ, Eitzman DT, and Moscucci M. Development of a Continuous Quality Improvement Program for the Reduction of Contrast Nephropathy After Percutaneous Coronary Intervention Circulation 108(17), IV-769, 2003 (Presented at the 76th Scientific session of the American Heart Association). 60. Ziada KM, Yadav JS, Lauer MS, Bhatt DL, Kapadia SR, Mukherjee D, Roffi M, Vora N, Tiong I and Bajzer C. Improved Outcomes with Carotid Stenting Prior to Open Heart Surgery Compared to Combined Carotid Endarterectomy and Open Heart Surgery Circulation 108(17), IV-632, 2003 (Presented at the 76th Scientific session of the American Heart Association). 38
  39. 39. 61. Mukherjee D, Giri K, Fang J, Chetcuti S, Moscucci M, Kline-Rogers E, and Eagle KA. Impact of Combination Evidence-Based Medical Therapy on Mortality in Patients With Acute Coronary Syndromes J Am Coll Cardiol; 43(5): Suppl A, 298A, 2004 (Presented at the 53rd Scientific session of the American College of Cardiology). 62. Nallamothu BK, Mukherjee D, Chetcuti S, Grossman PM, Dumasia R, Kline-Rogers E, Pitt B, Eagle KA and Moscucci M. Combination Evidence-Based Therapy Improves Survival After Percutaneous Coronary Intervention J Am Coll Cardiol; 43(5): Suppl A, 421A, 2004 (Presented at the 53rd Scientific session of the American College of Cardiology). 63. Patel D, Chetcuti S, Grossman P M, Mukherjee D, and Bates E. Catheter Sequence Rather Than Catheter Shape Determines The Frequency Of Cerebral Microemboli During Cardiac Catheterization J Am Coll Cardiol; 43(5): Suppl A, 471A, 2004 (Presented at the 53rd Scientific session of the American College of Cardiology). 64. Saab F, Fang J, Kline-Rogers E, Otten R, Eagle KA, and Mukherjee D. Early [within 24 hours] Statin Administration in Patients Presenting with Acute Coronary Syndrome is Associated with Better Outcomes Compared to Delayed [after 24 hours] Administration Circulation 110(17), Suppl III, III-498, 2004 (Presented at the 77th Scientific session of the American Heart Association). 65. Harada RK, Kline-Rogers EM, Fang J, Otten R, and Mukherjee D. Use of Evidence- Based Therapies in Patients with Chronic Kidney Disease Presenting with Acute Coronary Syndrome and Its Impact on Clinical Outcomes. Circulation 110(17), Suppl III, III-576, 2004 (Presented at the 77th Scientific session of the American Heart Association). 66. Otten R, Kline-Rogers E, Meier DJ, Dumasia R, May N, Resin Y, Sweis R, Fang J, Saab F, Petrina M, Eagle KA, and Mukherjee D. Impact of Prediabetic State on Clinical Outcomes in Patients With Acute Coronary Syndrome J Am Coll Cardiol; 45(3): Suppl 39
  40. 40. A, 198A, 2005 (Presented at the 54th Scientific session of the American College of Cardiology). 67. Mukherjee D, Eagle KA, Evangelista A, Sechtem U, Suzuki T, Trimarchi S, Llovet A, Myrmel T, O'Gara PT, Fang J, Cooper JV, Oh JK, Januzzi JL, Hutchison S, Fattori R, Pape LA, Isselbacher EM, Nienaber CA on behalf of the International Registry of Aortic Dissection (IRAD) investigators. Implications of Periaortic Hematoma in Patients With Acute Aortic Dissection: Insights From the International Registry of Aortic Dissection (IRAD) J Am Coll Cardiol; 45(3): Suppl A, 380A, 2005 (Presented at the 54th Scientific session of the American College of Cardiology). 68. Tsai TT, Nallamothu BK, Grossman PM, Mukherjee D, Chetcuti S, Moscucci M, and Bates ER. Does Facilitated Percutaneous Coronary Intervention Improve Angiographic and Clinical Outcomes in ST Elevation Myocardial Infarction? A Quantitative Review. J Am Coll Cardiol; 45(3): Suppl A, 243A, 2005 (Presented at the 54th Scientific session of the American College of Cardiology). 69. Mukherjee D, Eagle KA, Kline-Rogers E, Agnelli G, Budaj A, Avezum A, Allegrone J, Steg Ph G on behalf of the GRACE Investigators. Acute Coronary Syndrome as a Manifestation of Global Atherosclerosis – Impact of Prior Peripheral Arterial Disease and Stroke on Clinical Outcomes. The Global Registry of Acute Coronary Events (Presented at the European society of Cardiology Congress, September 2005, Stockholm, Sweden). 70. Jones N, Mukherjee D, Moscucci M, Froehlich JB, Chetcuti SJ, Munir K, Riba A, Person D, Bishop M, Karve M, and Grossman PM. If Not Now, When? Underutilization of Evidence Based Therapies in Patients Without Prior History of Coronary Artery Disease Undergoing Peripheral Vascular Intervention. Circulation 112(17), Suppl II, II-797, 2004 (Presented at the 78th Scientific session of the American Heart Association). 71. Latchamsetty R, Mukherjee D, Fang J, Kline-Rogers E, Otten R, Eagle KA, Froehlich JB. Prognostic Value of Transient and Sustained Rise of In-Hospital Creatinine 40
  41. 41. on Outcomes of Patients Admitted with Acute Coronary Syndrome Circulation 112(17), Suppl II, II-526, 2004 (Presented at the 78th Scientific session of the American Heart Association). 72. Fazel R, Mukherjee D, Saab F, May N, Kline-Rogers EM, Rogers BC, Fang J, Erickson S, Eagle KA. Improved Prescription of Evidence-Based Medications and Maintenance of High Adherence to These Medications in Acute Coronary Syndrome Patients After Implementation of Guidelines Applied in Practice J Am Coll Cardiol; 47(4): Suppl A, 254A, 2006 (Presented at the 55th Scientific session of the American College of Cardiology). 73. Das P, Moliterno DJ, Sneed D, Charnigo R, Mukherjee D, Steinhubl SR, Booth DC and Ziada KM. Impact of Drug-Eluting Stents on Outcomes of Patients With End-Stage Renal Disease Undergoing Percutaneous Coronary Revascularization J Am Coll Cardiol; 47(4): Suppl B, 28B, 2006 (Presented at the 55th Scientific session of the American College of Cardiology). 74. Jones NJ, Mukherjee D, Chetcuti SJ, Froehlich JB, Gurm H, Munir K, Luciano A, Riba A, Kassab EH, Sohal C, Person D, Karve M, Bishop M, Dunning D, Schaefer A, Moscussi and Grossman PM. Sex and Peripheral vascular Intervention: Does gender impact peri-procedural outcomes? Circulation (Presented at the 7th Scientific Forum on quality of care and outcomes research in cardiovascular disease and stroke). 75. Mukherjee D, Kline-Rogers E, Eagle KA, Feldman LJ, Juliard JM, Allegrone J, and Steg PG. Acute coronary syndrome as a manifestation of global atherosclerosis: impact of combination evidence-based therapy on mortality and morbidity in acute coronary syndrome. The GRACE registry Eur Heart J, 27 (Suppl 1), 224, August 2006 (Presented at the European society of Cardiology Congress, September 2006, Barcelona, Spain). 76. Das P, Ziada K, Hanna E, Falluji N, Booth D, Moliterno DJ and Mukherjee D. Do octogenarians benefit from drug eluting stents? Am J Cardiol 98(8), Suppl 1, TCT 434, 41
  42. 42. October 2006 (Presented at the Transcatheter Cardiovascular Therapeutics Symposium, October 2006, Washington, DC). 77. Dawson CB, Mukherjee D, Valgimigli M, Charnigo R, Walters DL, Danzi GB, Bolognese L, Moliterno DJ, and Topol EJ. Meta-analysis of High-dose Single-bolus Tirofiban versus Abciximab in Patients undergoing Percutaneous Coronary Interventions. Circulation 114 (18), Suppl, II-647 (Presented at the 79th Scientific session of the American Heart Association, 2006). 78. Mardikar HM, Hiremath MS, Moliterno DJ, Mathew R, Arora R, Deo D, Hiremath JS, Deshpande NV, Khan A, Joseph J, Mukherjee D. Optimal Platelet Inhibition in Patients Undergoing Percutaneous Coronary Intervention: Data From the MR PCI Study. J Am Coll Cardiol; 49(9): Suppl B, 34B, 2007 (Presented at the 56th Scientific session of the American College of Cardiology). 79. Mardikar HM, Deo D, Deshpande NV, Mardikar M, Steinhubl SR and Mukherjee D. Variability in platelet response to single daily dose of 150 mg aspirin in high risk population. Eur Heart J, 28 (Suppl 1), 664, August 2007 (Presented at the European society of Cardiology Congress, September 2007, Vienna, Austria). Books Rajagopalan S, Mukherjee D and Mohler E (eds). Manual of Vascular Medicine. Philadelphia, PA: Lippincott Raven, 2004 Mukherjee D (ed) Pharmacological Therapies for Peripheral Vascular Diseases, London, UK, Martin Dunitz, 2005 Mukherjee D (ed). ECG Cases pocket book. Germany, Borm Bruckmeier Publishing LLC, 2006 42
  43. 43. Mukherjee D, Cho L, Moliterno DJ (eds). 900 Questions: An interventional cardiology board review. Philadelphia, PA: Lippincott Raven, 2006 Mukherjee D, Rajagopalan S (eds). CT and MR Angiography of the Peripheral Circulation: Practical Approach with Clinical Protocols, London, Taylor and Francis, 2007 Roffi M, Abou-Chebl A and Mukherjee D (eds). Carotid Stenting: Indications and Results. Bremen, UNI-MED Publishing, 2008 Mukherjee D, Bates ER, Roffi, M and Moliterno DJ. Cardiac Catheterization, Coronary & Peripheral Angiography, and Interventional Procedures. London, Informa Healthcare, 2009 Multimedia CATHSAP 3, Associate Editor ACCSAP 7, Section editor, Cardiac Catheterization and Interventional Cardiovascular Medicine Book Chapters: 1. Mukherjee D. Complications of Acute Myocardial Infarction. In Marso S, Griffin BP, Topol EJ, eds. Manual of Cardiovascular Medicine. Philadelphia, PA: Lippincott Raven, 1999, pp 39 – 55. 2. Mukherjee D. Temporary Transvenous Pacemakers. In Marso S, Griffin BP, Topol EJ, eds. Manual of Cardiovascular Medicine. Philadelphia, PA: Lippincott Raven, 1999, pp 666 – 669. 3. Mukherjee D and Moliterno D. Bedside Platelet Monitoring. In Topol EJ eds. Acute Coronary Syndromes (2nd Edition). New York, NY: Marcel Dekker, 2000, pp 563 –597 43
  44. 44. 4. Mukherjee D, Wilkoff BL, Yadav JS. Angioplasty and Stenting of a Patient with Superior Vena Cava Syndrome. In: Fifty Cases in Peripheral Intervention. ed: Christopher White, MD, Martin Dunitz: London, 2002, pp 61-65 5. Mukherjee D and Yadav SJ. Cerebrovascular Diseases: Pathophysiology and Management. In Fuster V ed. Assessing and modifying the vulnerable atherosclerotic plaque. Armonk, NY: Futura Publishing, 2002, pp 29-55 6. Mukherjee D and Ellis SG. Rescue PCI for failed thrombolysis. In Cannon C, Tcheng JE, eds. Primary Angioplasty in Acute Myocardial Infarction. Totowa, NJ: Humana Press, 2002, pp 53-64 7. Mukherjee D and Yadav SJ. Status of randomized trials - SAPPHIRE. In Amor M, Bergeron P, Mathias K and Raithel D, eds. Carotid Artery: Angioplasty and stenting Turin, Italy: Edizioni Minerva Medica, 2002, pp 268-272 8. Mukherjee D. Device Genomics. In Topol EJ, Textbook of Interventional Cardiology (4th Edition). Philadelphia, PA: W.B. Saunders, 2002, pp 1043-1052 9. Mukherjee D, Bates ER, and Hochman JS. Cardiogenic Shock – SHOCK Trial Perspective. In Morrison D ed. High risk cardiac revascularization and clinical trials. London, UK, Martin Dunitz, 2002, pp 327-335 10. Mukherjee D. Coronary Artery Disease In Cho L, Griffin B and Topol EJ (eds) The Cardiology Intensive Board Review Question Book. Philadelphia, PA: Lippincott Raven, 2003, pp 105 – 157 11. Roffi M and Mukherjee D. Glycoprotein IIb/IIIa inhibitors. In de Marchena E and Ferreira (eds), Interventional Cardiology Secrets. Philadelphia, PA: Hanley & Belfus, Inc., 2003, pp 81-84 44
  45. 45. 12. Mukherjee D and Bates ER. Acute ST elevation myocardial infarction. In Eagle KA, Practical Cardiology. Philadelphia, PA: Lippincott Williams & Wilkins, 2003, pp 170-187 13. Mukherjee D. Cardiovascular system. In Haessler I and Maute C (eds). Drug Therapy Pocket 2003-2004. Hermosa beach, CA: Borm Bruckmeier Publishing, 2003, pp 11-42. 14. Mukherjee D and Yadav SJ. Carotid angioplasty and stenting. In Heuser RR and Henry M. Textbook of peripheral vascular intervention. London, UK: Martin Dunitz, 2003, pp 333-339 15. Dumasia R and Mukherjee D. Adjunctive Pharmacology such as antithrombotics, vasodilators, sedation/pain medication, pressors. In Bhatt DL (ed). Essential Concepts in cardiovascular Intervention: Self Assessment and Review, Remedica Publishing 2003, pp 115-127 16. Mukherjee D and Eagle KA. Perioperative Evaluation and Management of Patients with Known or Suspected Cardiovascular Disease Who Undergo Noncardiac Surgery. In Fuster V, Roberts R, Alexander RW, O’Rourke R, King S, Nash I and Prystowski E (eds) Hurst’s The Heart 11th Edition, Philadelphia, PA: McGraw-Hill, 2004, pp 2037-2049 17. Mukherjee D and Asher C. (Section Editors) Miscellaneous Conditions. In: Roffi M, Meier B, Topol EJ (eds): CVMstat®. A Comprehensive Handheld-Based Approach to CardioVascular Medicine. Handheldmed Inc., Little Rock, AR, USA, 2004. 18. Mukherjee D and Eagle KA. Cardiac Risk in Non-cardiac Surgery. In: Roffi M, Meier B, Topol EJ (eds): CVMstat®. A Comprehensive Handheld-Based Approach to CardioVascular Medicine. Handheldmed Inc., Little Rock, AR, USA, 2004. 45
  46. 46. 19. Mukherjee D. Diagnostic Catheter-based Vascular Angiography. In Rajagopalan S, Mukherjee D and Mohler E (eds). Manual of Vascular Medicine. Philadelphia, PA: Lippincott Raven, 2004, pp 28-47 20. Mukherjee D, Olin J, and Rajagopalan SR. Renovascular Disease – Diagnosis and Management. In Rajagopalan S, Mukherjee D and Mohler E (eds). Manual of Vascular Medicine. Philadelphia, PA: Lippincott Raven, 2004, pp 120-134 21. Roffi M and Mukherjee D. Approach to carotid Artery disease. In Rajagopalan S, Mukherjee D and Mohler E (eds). Manual of Vascular Medicine. Philadelphia, PA: Lippincott Raven, 2004, pp 135-155 22. Mukherjee D and Rajagopalan SR. Subclavian, Innominate and Axillary Arterial Disease. In Rajagopalan S, Mukherjee D and Mohler E (eds). Manual of Vascular Medicine. Philadelphia, PA: Lippincott Raven, 2004, pp 227-237 23. Mohler E, Mukherjee D, and Rajagopalan SR. Upper Extremity Deep Vein and Superior Vena Cava (SVC) Thrombosis In Rajagopalan S, Mohler E and Mukherjee D (eds). Manual of Vascular Medicine. Philadelphia, PA: Lippincott Raven, 2004, pp 325-335 24. Dumasia R and Mukherjee D. Hemodialysis Access. In Rajagopalan S, Mukherjee D and Mohler E (eds). Manual of Vascular Medicine. Philadelphia, PA: Lippincott Raven, 2004, pp 390-397 25. Mukherjee D and Cho L. Renal and mesenteric artery stenosis. In Bhatt DL (ed). Handbook of peripheral and cerebrovascular intervention, Remedica Publishing 2004, pp 107-121 26. Mukherjee D and Moliterno D. Bedside Platelet Monitoring. In Topol EJ (ed). Acute Coronary Syndromes (3rd Edition). New York, NY: Marcel Dekker, 2004, pp 481-505 46
  47. 47. 27. Mukherjee D and Eagle KA. Pre and Post-operative Management of Cardiovascular Diseases and Risks in Patients with Peripheral Vascular Disease. In Abela G, Textbook of Peripheral Vascular Diseases, Philadelphia, PA: W.B. Saunders, 2004, pp 353-364 28. Mukherjee D. Peripheral Vascular Occlusive Disease (PVOD) – Claudication. In Upchurch G and Henke, P (eds). Clinical Scenarios of Vascular Surgery, Philadelphia, PA: Lippincott Williams & Wilkins, 2005, pp 231-235 29. Mukherjee D. Arterial venous fistula in Groin Following Cardiac catheterization. In Upchurch G and Henke, P (eds). Clinical Scenarios of Vascular Surgery, Philadelphia, PA: Lippincott Williams & Wilkins, 2005, pp 259-264 30. Mukherjee D. Arthritis and Cardiovascular Events. In Topol EJ (ed). Textbook of Cardiovascular Medicine – Update Series, Volume 8; Number 2, Philadelphia, PA: Lippincott Williams & Wilkins, 2005, pp 1- 14 31. Mukherjee D and Moliterno DJ. Monitoring Anticoagulants in the Catheterization Laboratory and in the ICU when using Combination Therapies. In Becker RC, Harrington RA (eds) The Practice of clinical, interventional, and investigational thrombocardiology. Philadelphia, PA: W.B. Saunders, 2005, pp 257-273 32. Mukherjee D and Eagle KA. Practical Principles of Quality Measurement and Cost Effectiveness Analysis in Cardiovascular Medicine and Surgery. In ACCSAP VI [American College of Cardiology], 2005, pp 1-22 http://www.acc.org/education/products/accsap6_chapters.htm 33. Mukherjee D. Lifestyle Changes and Risk factor Modification. In Mukherjee D (ed) Pharmacological Therapies for Peripheral Vascular Diseases, London, UK, Taylor & Francis, 2005, pp 3-10 47
  48. 48. 34. Eagle K and Mukherjee D. Pharmacotherapy for Global Cardiovascular Risk Reduction. In Mukherjee D (ed) Pharmacological Therapies for Peripheral Vascular Diseases, London, UK, Taylor & Francis, 2005, pp129-138 35. Pitt B, Mukherjee D and Rajagopalan SR. Renin-Angiotensin-Aldosterone-System [RAAS] Blockade in Peripheral Arterial Diseases. In Mukherjee D (ed) Pharmacological Therapies for Peripheral Vascular Diseases, London, UK, Taylor & Francis, 2005, pp 65-74 36. Mukherjee D and Eagle KA. Preoperative Cardiac Assessment In Zelenock, Lumsden, Messina, Moneta, and Huber (eds) Mastery of Vascular and Endovascular Surgery, Philadelphia, PA: Lippincott Williams & Wilkins, 2005, pp 47-54 37. Mukherjee D and Rosenfield K. Vertebral Artery Intervention. In Casserly I, Sachar R and Yadav J (eds). The Manual of Peripheral Vascular Intervention. Philadelphia, PA: Lippincott Williams & Wilkins, 2005, pp 110-119 38. Mukherjee D and Eagle KA. Aortic Dissection In Bax, Kramer, Marwick and Wijns (eds) Optimal Use of cardiovascular Imaging in Clinical Practice, Victoria, Australia, Blackwell Publishing, Malden, MA, 2005, pp 49-60 39. Saraff KY, Mukherjee D, Moliterno DJ. 1Monitoring of Anti-thrombotic Drugs, In Kristensen SD, Caternia R De, Moliterno DJ (eds). Therapeutic Strategies in Thrombosis, Oxford, UK, Clinical Publishing Co., Inc., 2005, pp 359-383 40. Mukherjee D. Emerging Treatment Modalities in Coronary Artery Disease. In Kohli K, Gupta M and Tejwani S (eds). Current Therapeutics in Clinical Practice, New Delhi, India, Elsevier, 2006, pp 282-292. 41. Mukherjee D and Eagle KA. Assessment of Preoperative Risk. In Mulholland MW, Doherty GM (eds). Complications in Surgery, Philadelphia, PA: Lippincott Williams & Wilkins, 2006, pp 57-66 48
  49. 49. 42. Falluji N and Mukherjee D. Cerebrovascular interventions. In Mukherjee D, Cho L, Moliterno DJ (eds). 900 Questions: An interventional cardiology board review. Philadelphia, PA: Lippincott Raven, 2006, pp 225-232 43. Cho L and Mukherjee D. Closure Devices. In Mukherjee D, Cho L, Moliterno DJ (eds). 900 Questions: An interventional cardiology board review. Philadelphia, PA: Lippincott Raven, 2006, pp 164-169 44. Mukherjee D, Moliterno DJ, Cho L Primary, Rescue and Facilitated Angioplasty In Mukherjee D, Moliterno DJ, Cho L (eds). 900 Questions: An interventional cardiology board review. Philadelphia, PA: Lippincott Raven, 2006, pp 88-96 45. Das P, Dutta M and Mukherjee D. Heparin-induced Thrombocytopenia In ACCSAP VI [American College of Cardiology] http://www.cardiosource.com/GenSAP/Chapter.asp?ProductID=40&ChapterID=2207 46. Das P, Dutta M and Mukherjee D. Hypercoaguable Syndromes. In ACCSAP VI [American College of Cardiology] http://www.cardiosource.com/GenSAP/Chapter.asp?ProductID=40&ChapterID=2207 47. Mukherjee D and Januzzi JL. Long-term Medical Therapy in Aortic Dissection In Baliga, Isselbacher, Nienaber and Eagle (eds) Aortic Dissection, New York, NY, Kluwer Academic Publishers, 2007, pp 193-198 48. Mukherjee D and Eagle KA. Prevention of Aortic Dissection In Baliga, Isselbacher, Nienaber and Eagle (eds) Aortic Dissection, New York, NY, Kluwer Academic Publishers, 2007, pp 347-350 49. Falluji N and Mukherjee D. Lower extremity interventions. In Topol EJ, Textbook of Interventional Cardiology, 5th Edition. Philadelphia, PA: W.B. Saunders, 2007, pp 689-708 49
  50. 50. 50. Das P and Mukherjee D. Bioabsorbable stents. In Topol EJ, Textbook of Interventional Cardiology, 5th Edition. Philadelphia, PA: W.B. Saunders, 2007, pp 601-618 51. Ziada K and Mukherjee D. Peri-Procedural MI and Emboli Protection. In Topol EJ, Textbook of Interventional Cardiology, 5th Edition. Philadelphia, PA: W.B. Saunders, 2007, pp 491-512 52. Mukherjee D and Eagle KA. Perioperative Evaluation and Management of Patients with Known or Suspected Cardiovascular Disease Who Undergo Noncardiac Surgery. In Fuster V, O’Rourke R, Walsh RA and Poole-Wilson PA (eds) Hurst’s The Heart 12th Edition, Philadelphia, PA: McGraw-Hill, 2007, pp 2038-2047 53. Mukherjee D and Rajagopalan SR. X-Ray Contrast Agents and Contrast Timing Considerations. In Mukherjee D, Rajagopalan S (eds). CT and MR Angiography of the Peripheral Circulation: Practical Approach with Clinical Protocols, London, Taylor and Francis, 2007, pp 53-62 54. Nallamothu B, Mukherjee D and Bates ER. Acute ST elevation myocardial infarction. In Eagle KA, Practical Cardiology (2nd Edition). Philadelphia, PA: Lippincott Williams & Wilkins, 2003, pp 196-218 55. Mukherjee D and Moliterno DJ. Heparin-induced Thrombocytopenia In CATHSAP 3 [Catheterization and Interventional Cardiology Self-Assessment Program], 2008 http://www.acc.org/education/products/cathsap3.htm 56. Mukherjee D and Moliterno DJ. Hypercoagulable Disorders In CATHSAP 3 [Catheterization and Interventional Cardiology Self-Assessment Program], 2008 http://www.acc.org/education/products/cathsap3.htm 50
  51. 51. 57. Moliterno DJ and Mukherjee D. Chronic Total Occlusion In CATHSAP 3 [Catheterization and Interventional Cardiology Self-Assessment Program], 2008 http://www.acc.org/education/products/cathsap3.htm 58. Mukherjee D. Aortic Dissections In CATHSAP 3 [Catheterization and Interventional Cardiology Self-Assessment Program], 2008 http://www.acc.org/education/products/cathsap3.htm 59. Pineda G and Mukherjee D. Lower extremity: Contrast imaging studies. In Richard Heuser and Michel Henry (Eds) Textbook of Peripheral Vascular Interventions 2nd edition, London, Taylor and Francis, 2008 60. Mukherjee D. Cardiovascular Disease in patients with carotid stenosis. In Roffi M, Abou-Chebl A and Mukherjee D (eds). Carotid Stenting: Indications and Results. Bremen, UNI-MED Publishing, 2008 61. Mukherjee D. Carotid Stenting Equipment. In Roffi M, Abou-Chebl A and Mukherjee D (eds). Carotid Stenting: Indications and Results. Bremen, UNI-MED Publishing, 2008 62. Mukherjee D. Secondary Prevention and follow-up. In Roffi M, Abou-Chebl A and Mukherjee D (eds). Carotid Stenting: Indications and Results. Bremen, UNI-MED Publishing, 2008 63. Das P and Mukherjee D. Coronary artery disease in Peripheral Arterial Disease. In Dieter RS (ed) Peripheral Arterial Disease. McGraw-Hill Professional, 2008 64. Dawson CB, Mukherjee D and Moliterno DJ. High Dose Tirofiban In Waksman R and Ajani A (eds) Pharmacology in the Cath Lab, Blackwell Publishing, 2008 51
  52. 52. 65. Mukherjee D and Roffi M. Coronary Artery Disease In Cho L and Griffin B (eds) The Cardiology Intensive Board Review Question Book (2nd Edition). Philadelphia, PA: Lippincott Raven, 2008 66. Mukherjee D. Right and Left Heart Catheterization, Myocardial, Valvular, and Pericardial Disease In ACCSAP 7 [American College of Cardiology] 67. Mukherjee D. Coronary Angiography: Indications, Contraindications, and Complications In ACCSAP 7 [American College of Cardiology] 68. Mukherjee D. Catheter Selection, Coronary Artery Anatomy and Anomalies, Physiologic Assessment of Coronary Stenoses, and Intravascular Ultrasound In ACCSAP 7 [American College of Cardiology] 69. Roffi M, Mukherjee D and Windecker S. Percutaneous Coronary Intervention, Coronary Artery Stents In ACCSAP 7 [American College of Cardiology] 70. Dunn S, Macauley T and Mukherjee D. Antiplatelet and Antithrombotic Agents During Percutaneous Coronary Intervention In ACCSAP 7 [American College of Cardiology] 71. Pineda G and Mukherjee D. Balloon Angioplasty, Atherectomy, Distal Embolic Protection Devices, and Total Occlusion Crossing Devices In ACCSAP 7 [American College of Cardiology] 72. Das P and Mukherjee D. High-Risk Subsets for Percutaneous Coronary Intervention and Complications In ACCSAP 7 [American College of Cardiology] 73. Roffi M, Mukherjee D and Windecker S. Restenosis and Stent Thrombosis In ACCSAP 7 [American College of Cardiology] 52
  53. 53. 74. Roffi M and Mukherjee D. Peripheral Arterial Angiography, Carotid Angiography and Interventions In ACCSAP 7 [American College of Cardiology] 75. Mukherjee D. Training Standards and Proficiency In ACCSAP 7 [American College of Cardiology] 76. Mukherjee D. Renal Artery Disease In Garcia M (ed) Textbook of Non-Invasive Cardiovascular Imaging: The Modern Approach to Cardiovascular Diagnosis and Therapeutic Guidance (1st Edition). Philadelphia, PA: Lippincott Raven, 2009 77. Mukherjee D, Jacobs BS, Hickenbottom S and Eagle KA. Nonatherosclerotic Large Vessel Disease. In Cho L, Schneck MJ (eds) Cerebrovascular Disease – A cardiac perspective, Elmsford, NY: Blackwell/Futura, 2009 Invited Lectures Ultrasound mediated enhancement of myocardial uptake of systemically applied growth factors (Angiogenesis and Direct Myocardial Revascularization National Meeting, 1999) Therapeutic Angiogenesis and newer modalities of therapy in the treatment of coronary artery disease (Cleveland Clinic Foundation Internal medicine Grand rounds, July 6, 2000) Peripheral vascular diseases: Patient presentation, evaluation and current therapy options (Cleveland Clinic Cardiology Board Review, September 26, 2000) Carotid Stenting in High-Risk Patients (International Society of Endovascular Therapy, Miami, Jan 23, 2001) Update on Carotid Clinical Trials: SAPPHIRE (International Society of Endovascular 53
  54. 54. Therapy, Miami, Jan 23, 2001) Newer modalities of therapy in the treatment of Coronary Artery Disease (University of Michigan cardiology Grand rounds, Feb 12, 2001) Significant renal artery stenosis requires medical management (9th Annual New Devices Seminar, June 30 – July 3, Orlando, Florida) Angiographic Techniques and Anatomy for Cerebrovascular Disease (9th Annual New Devices Seminar, June 30 – July 3, Orlando, Florida) COX-2 inhibitors and cardiovascular risk (Cybersession on Heart.org, 22nd Aug 2001) http://dev.cybersessions.com/conference/22aug01/ Carotid Stenting: Techniques & cerebral protection - current and future devices (3rd Annual Great Lakes Endovascular Symposium, October 20, 2001, Dearborn, Michigan) Has carotid stenting eclipsed endarterectomy? (3rd Annual Great Lakes Endovascular Symposium, October 20, 2001, Dearborn, Michigan) Therapeutic Angiogenesis (53rd Annual Conference of the Cardiological Society of India, December 6 - 9, 2001, Hyderabad, India) Coronary Catheterization and Intervention: Why diabetics are different (University of Michigan, Update in Internal Medicine, May 2-4, 2002) Diagnosis and Management of Renal and Peripheral Vascular Diseases (Cleveland Clinic Foundation, Cleveland, Ohio, Cardiology Grand Rounds, May 31, 2002) Advances in Interventional Cardiology: Drug eluting stents and emboli protection devices (University of Michigan Cardiovascular Center Nursing Symposium, June 3-4, 2002) 54
  55. 55. Management of Peripheral Vascular Diseases (Henry Ford Hospital and Vascular Institute, Detroit, Michigan, Cardiology Grand Rounds, July 24, 2002) Creating New Paradigms in the Treatment of Acute Coronary Syndromes. (Michigan State University Primary Care Symposium, August 16th, 2002) Acute Coronary Syndromes (Congdon Lecture Series, Genesys Medical Center, October 9th, 2002) Peripheral Vascular Interventions: Current Role of Cardiologists (University of Michigan Cardiology Grand Rounds, December 3rd, 2002) Peripheral Vascular Interventions: Current Role for Cardiology (The 25th annual American College of Cardiology conference at Big Sky, Feb 19th 2003, Montana) Role and Controversies of Antithrombin Therapy in Acute Coronary syndromes (The 4th annual Antithrombotic Therapy Symposium at Dearborn, Michigan, March 5th, 2003) Clinical Impact of Current Acute Coronary Syndrome Studies for the Primary Care Physician (Primary Care Update, Muskegon, Michigan, March 19th, 2003) Percutaneous Treatment of PVD (Controversies in Peripheral Vascular Disease, Loyola University School of Medicine, March 29th, 2003) Carotid and Renal Artery Stenosis: Endovascular Therapy (Henry Ford Hospital and Vascular Institute, Detroit, Michigan, Cardiology Grand Rounds, July 29th, 2003) Peripheral Vascular Disorders (Internal Medicine Grand Rounds, McLaren Regional Medical Center, Flint, Michigan, September 5th, 2003) Peripheral Arterial Disease (Primary Care Update, Metropolitan Hospital, Grand Rapids, 55
  56. 56. Michigan, November 1st, 2003) Further Management of a Patient Discharged with the Diagnosis “Acute Coronary Syndrome” (Updates in Primary Care IV – Office cardiology for the Primary care Physician, November 22nd, 2003) Peripheral Arterial Disease – Epidemiology, Diagnosis and Management – (State of the Heart address at the Loyola University Medical center, November 26th, 2003) Diabetes, Coronary Artery Disease and Revascularization - (University of Michigan Cardiology Grand Rounds, December 9th, 2003) Risk factors and their modification: Can ischemic events be avoided? – (Peripheral Arterial Disease – The Silent Killer, January 10th, Jobst Vascular Center, Toledo, Ohio) Pharmacotherapy for global cardiovascular risk reduction and PAD – (Peripheral Arterial Disease – The Silent Killer, January 10th, Jobst Vascular Center, Toledo, Ohio) Antiplatelet Agent and peripheral arterial disease – (St Mary Mercy Hospital, Livonia, Michigan, Internal Medicine Grand Rounds 4th February 2004) Beta-blockers must be used to reduce cardiovascular mortality in diabetics – (Coronary Artery Disease 2004, February 20th – 22nd, Mumbai, India) Effective Antiplatelet therapy – (Coronary Artery Disease 2004, February 20th – 22nd, Mumbai, India) Limb Ischemia – (Coronary Artery Disease 2004, February 20th – 22nd, Mumbai, India) Carotid Stenting – Anatomy (American College of Cardiology Interventional symposium, 53rd Scientific session of the American College of Cardiology, March 9th, 2004, New Orleans, LA) 56
  57. 57. Percutaneous Revascularization: Well Beyond the Coronary Arteries (Kentucky Chapter of the American college of cardiology - What's New in Clinical Cardiology? Exploring Facts and Fiction, October 9th, 2004, Lexington, Kentucky) Invited Discussant – REACT Trial (American Heart Association Scientific Sessions, November 7th, 2004, New Orleans, LA) Diabetes, Coronary Artery Disease and Revascularization (University of Kentucky Cardiovascular seminar series, January 28th, 2005, Lexington, Kentucky) Expectation of Trial Design: Cardiovascular Perspective (Cardiovascular Effects of Selective Cox-2 Inhibition: Is there a Class Effect? International Cox-2 Study group Meeting, January 28th – 30th, 2005, Washington, DC) Aortic dissection: Evaluation and Management – (Coronary Artery Disease 2005, February 10th – 13th, Agra, India) Pre-op Evaluation of the Non-cardiac Surgery Patient – (Coronary Artery Disease 2005, February 10th – 13th, Agra, India) Emboli Protection Devices in PCI – (Coronary Artery Disease 2005, February 10th – 13th, Agra, India) Peripheral Vascular Disease – Pathophysiology, Diagnosis and Management – (Internal Medicine Grand rounds, University of Kentucky, April 29th 2005) Peripheral Vascular Disease – Contemporary Management – (Cardiology Grand rounds, St John Hospital, Michigan, July 27th 2005) Cardiology Urgencies and Emergencies for the Hospitalist (Hospitalist CME Series, San Diego, September 12th, 2005) 57
  58. 58. Cardiology Urgencies and Emergencies for the Hospitalist (Hospitalist CME Series, Philadelphia, September 26th, 2005) Cardiology Urgencies and Emergencies for the Hospitalist (Hospitalist CME Series, Atlanta, October 17th, 2005) Cardiology Urgencies and Emergencies for the Hospitalist (Hospitalist CME Series, Houston, November 7th, 2005) Renal Angioplasty only if BP is uncontrolled– (Coronary Artery Disease 2006, January 13th, Mumbai, India) Aggressive platelet Inhibition is must in Diabetes with CAD (Coronary Artery Disease 2006, January 13th, Mumbai, India) Angiogenesis and regeneration of heart muscles in management of Heart failure – (Coronary Artery Disease 2006, January 15th, Mumbai, India) Interventional treatment of peripheral arterial Disease (Innovations in intervention, 55th Scientific Sessions of the American College of Cardiology, Atlanta, Georgia, March 12th, 2006) COX-2 Inhibitors and Cardiovascular Risk, Co-Chair (55th Scientific Sessions of the American College of Cardiology, Atlanta, Georgia, March 13th, 2006) Tips for Safe and Effective Carotid Stenting, (Meet the Experts @ the 55th Scientific Sessions of the American College of Cardiology, Atlanta, Georgia, March 13th, 2006) The Management of Peripheral Arterial Disease (Cardiovascular Medicine and Surgery: The latest in medications and Techniques, Southern Kentucky AHEC, April 11, 2006) 58

×